cephalosporin c has been researched along with cefaclor anhydrous in 248 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 66 (26.61) | 18.7374 |
| 1990's | 132 (53.23) | 18.2507 |
| 2000's | 43 (17.34) | 29.6817 |
| 2010's | 4 (1.61) | 24.3611 |
| 2020's | 3 (1.21) | 2.80 |
| Authors | Studies |
|---|---|
| Loch, R; Schröter, G | 2 |
| Andrews, JM; Dean, S; Kendall, MJ; Welling, PG; Wise, R | 1 |
| Braveny, I; Dickert, H; Machka, K | 1 |
| Schassan, HH | 1 |
| Flensberg, T; Wiedemann, B | 1 |
| Barry, AL; Fuchs, PC; Gavan, TL; Gerlach, EH; Jones, RN; Thornsberry, C | 1 |
| Dean, S; Kendall, MJ; Selen, A; Welling, PG; Wise, R | 2 |
| Johnson, DM; Jones, RN | 1 |
| Allen, SD; Erwin, ME; Gerlach, EH; Jones, RN; Koontz, FP; Murray, PR; Pfaller, MA; Washington, JA | 2 |
| Fah, YS; Powell, M; Seymour, A; Williams, JD; Yuan, M | 1 |
| Cullmann, W; Knöller, J; König, W; Scheffer, J | 1 |
| Arias, G; Bolaños, HJ; Faingezicht, I; Guevara, J; Ruiz, M | 1 |
| Bergin, L; Dantzig, AH; Tabas, LB | 1 |
| Hatakeyama, K; Hori, M; Nakano, K; Sakaguchi, N; Sugita, M; Toyonaga, Y; Yamazaki, M; Yamori, K | 1 |
| Barry, AL; Doern, GV; Ferraro, MJ; Jorgensen, JH; Murray, PR | 1 |
| Hanfling, MJ; Hausinger, SA; Squires, J | 1 |
| Indelicato, JM; Pasini, CE | 1 |
| Crokaert, F; Van der Linden, MP; Yourassowsky, E | 1 |
| Arguedas, AG; Stutman, HR | 1 |
| McCarty, JM; Renteria, A | 1 |
| Pelletier, LL | 1 |
| Nolen, TM | 1 |
| Jacobson, KD; McCarty, J; Ruoff, GE | 1 |
| Bischoff, W; Hyslop, DL | 1 |
| Bischoff, W; Iravani, A | 1 |
| Aiken, S; Cassano, KB; Chirurgi, VA; Edelstein, H; Karp, R; Krumpe, P; McCabe, RE; Oster, SE | 1 |
| Christenson, JC; Gooch, WM; Herrod, JN; Swenson, E | 2 |
| Brumfitt, W; Hamilton-Miller, JM | 2 |
| Brier, G; Kovach, PM; Lantz, RJ | 1 |
| Iravani, A | 2 |
| Katsumata, Y; Moore, CM; Sato, K | 1 |
| Lionell, C; Magni, L | 1 |
| Boucherat, M; Bouhanna, A; Cohen, R; de la Rocque, F; Elbez, A; Lecompte, MD; Wollner, A | 1 |
| Gomi, K; Hiraga, Y; Konishi, K; Nakayama, I; Ohmichi, M; Oizumi, K; Saito, A; Tamura, M; Tomizawa, M; Watanabe, A | 1 |
| Derriennic, M; Dubreuil, L; Sedallian, A | 1 |
| Barbhaiya, RH; Gleason, CR; Martin, RR; Pittman, KA; Shukla, UA; Shyu, WC; Wilber, RB | 1 |
| Barbhaiya, RH; Gleason, CR; Pittman, KA; Shukla, UA; Shyu, WC; Wilber, RB | 1 |
| Barbhaiya, RH; Gleason, CR; Pittman, KA; Shukla, UA; Shyu, WC | 1 |
| Cocchetto, DM; Gwaltney, JM; Scheld, WM; Sydnor, A | 1 |
| Lindmark, A; Nord, CE; Persson, I | 1 |
| Hirata, T; Matsukuma, I; Mochida, K; Okachi, R; Sato, K | 1 |
| Iravani, A; Richard, GA | 1 |
| Sheeler, RD | 1 |
| Aronovitz, GH | 1 |
| Ando, M; Hashimoto, I; Mizuno, A; Morimoto, K; Nakamura, T; Sakai, K; Shinagawa, N; Ueda, T; Watanabe, S; Yura, J | 1 |
| Fujita, K; Sakata, H; Yoshioka, H | 1 |
| Noel, GJ; Teele, DW | 1 |
| Ishikawa, K; Ito, T; Kawai, S; Kobayashi, H; Nakayama, I; Saito, A; Takeuchi, K; Tamura, M; Tomizawa, M; Yajima, O | 1 |
| Buck, RE; Chisholm, DR; Desiderio, JV; Kessler, RE; Leitner, F; Misiek, M; Pursiano, TA; Tsai, YH | 1 |
| Beskid, G; Durkin, JW; Fallat, V; Lipschitz, ER; McGarry, DH; Siebelist, J | 1 |
| Fontana, R; Pelosi, E | 1 |
| Miyahara, T; Nakayama, I; Onodera, S; Saito, A; Sasaki, N; Shiba, K; Shimada, J; Tamura, M; Tomizawa, M | 2 |
| Barry, AL; Jones, RN | 5 |
| Matsubara, T; Mizuno, A; Nakashima, M; Takiguchi, Y; Uchida, K; Uematsu, T | 1 |
| Kamimura, T; Kikuchi, H; Kuwahara, S; Mine, Y; Shibayama, F; Tawara, S; Wakai, Y; Yokota, Y | 1 |
| Niederriter, K; Norden, CW | 1 |
| Chin, NX; Neu, HC | 1 |
| Anthony, WC; Craig, W; File, TM; Lifland, P; Schleupner, CJ; Tan, J; Vogelman, B | 1 |
| Kurtz, B; Paz, R; Soback, S; Ziv, G | 1 |
| Knapp, CC; Washington, JA | 1 |
| Allen, SD; Ayers, LW; Barry, AL; Fuchs, PC; Jones, RN; Pfaller, M | 1 |
| Braveny, I; Machka, K | 1 |
| Bentz, EJ; Frey, JJ; Furr, SJ; Ives, TJ | 1 |
| Ayers, LW; Barry, AL; Fuchs, PC; Gavan, TL; Gerlach, EH; Jones, RN | 1 |
| Eliopoulos, GM; Moellering, RC; Reiszner, E; Wennersten, C | 1 |
| Hamana, Y; Inoue, M; Mitsuhashi, S; Okamoto, S | 1 |
| Ando, S; Hirano, M; Kawaguchi, H; Kondo, S; Masuyoshi, S; Miyaki, T; Tomatsu, K | 1 |
| Hiraoka, M; Inoue, M; Masuyoshi, S; Mitsuhashi, S; Tomatsu, K | 1 |
| Brown, GW; Cox, DM; Hebblethwaite, EM; Plested, SJ; Williams, KJ | 1 |
| Lindgren, K | 1 |
| Faulkner, RD; Hiltke, MF; McAteer, JA; Silber, BM | 1 |
| Peeters, M; Piot, P | 1 |
| Chau, PY; Leung, YK; Ng, WS; Wong, PC | 1 |
| Nakamura, M; Nakashima, E; Tsuji, A; Yamana, T | 1 |
| Aznar, J; Borobio, MV; Garcia, F; Jimenez, R; Perea, EJ | 1 |
| Bianchi, P; Frongillo, RF | 1 |
| Brogard, JM; Comte, F | 1 |
| Chao, HP; Ho, SW; Hsieh, WC; Luh, KT | 1 |
| Fujishita, Y; Kaizu, M; Kojo, H; Matsumoto, Y; Shigi, Y | 1 |
| Goto, S; Kamimura, T; Kojo, H; Kuwahara, S; Matsumoto, Y; Mine, Y | 1 |
| Balsamo, A; Broccali, G; Giani, R; Macchia, B; Macchia, F; Pifferi, G; Pinza, M; Rossello, A | 1 |
| Ullmann, U | 1 |
| Barry, AL; Jones, RN; Preston, DA; Thornsberry, C | 1 |
| Weinstein, AJ | 1 |
| Hsu, CY; Prime, DJ; Tune, BM; Wang, PL | 1 |
| Bucholz, RW; Kusmiesz, H; Nelson, JD; Shelton, S | 1 |
| Ginsburg, CM | 1 |
| Nightingale, C | 1 |
| Halter, F; Lebek, G; Ohnhaus, EE | 1 |
| Kofron, WG; Potter, JL; Timmons, GD | 1 |
| Blumer, JL; Deabate, CA; Kafetzis, DA; Mclinn, SE; Perrotta, RJ; Salgado, O | 1 |
| Köhler, W; Schenk, P | 1 |
| Appelbaum, PC; Jacobs, MR; Spangler, SK | 1 |
| Nishino, T; Ohya, S; Takenouchi, T; Utsui, Y | 1 |
| Kurochkina, VB; Larina, EL; Libinson, GS; Nys, PS | 1 |
| McCarty, JM | 1 |
| Ball, P | 1 |
| Kafetzis, DA | 1 |
| Nolen, T | 1 |
| Doern, GV; Gerlach, EH; Hindler, J; Jones, RN; St Amand, R | 1 |
| Garcia Iglesias, MC; Perea, EJ | 1 |
| Fung-Tomc, JC; Kessler, RE | 1 |
| Nicolau, DP; Nightingale, CH; Onyeji, CO; Quintiliani, R | 1 |
| Andrews, JM; Lees, AS; Wise, R | 1 |
| Baertschi, SW; Collins, MW; Dorman, DE; Lorenz, LJ; Occolowitz, JL; Paschal, JW; Skibic, MJ; Spangle, LA; Taylor, KW | 1 |
| Berman, S; Roark, R | 1 |
| Kamme, C; Petersson, AC | 1 |
| McCabe, R; Mogabgab, W; Perrotta, R; Rumans, L | 1 |
| Manz, HJ; Schellinger, D; Stehbens, WE; Uszinski, R | 1 |
| Koga, T; Takeshita, T; Yashima, Y | 1 |
| Liston, TE | 1 |
| Grammer, LC | 1 |
| Issopoulos, PB; Salta, SE | 1 |
| Cappelletty, DM; Rybak, MJ | 1 |
| Li, G; Wu, J; Zhang, Y | 1 |
| Akimoto, Y; Fujii, A; Kaneda, T; Kaneko, K; Kawana, T; Nishimura, H; Omata, H; Shibutani, J; Yamamoto, H | 1 |
| Hidalgo, IJ; Li, J | 1 |
| Reynolds, RD | 1 |
| Aleo, G; Blandino, G; Caccamo, F; Nicolosi, VM; Siracusa, V; Speciale, A | 1 |
| Rodriguez, AF | 1 |
| O'Doherty, B | 1 |
| Montero, L | 1 |
| Idoate, I; Larralde, J; Mendizábal, MV; Urdaneta, E | 1 |
| Curran, R; Towner, KJ; Webster, CA | 1 |
| Gürses, N; Islek, I; Kalayci, AG; Uysal, S | 1 |
| Hall, G; Heimdahl, A; Nord, CE | 1 |
| Anastasiou, A; Leotsacos, P; Pavlopoulou, J; Sereti, E; Syriopoulou, V | 1 |
| Abramson, O; Dagan, R; Fliss, DM; Goshen, S; Greenberg, D; Lang, R; Leiberman, A; Leibovitz, E; Yagupsky, P | 2 |
| Robinson, J | 1 |
| Nagayama, H; Nakamura, Y; Shinkai, H | 1 |
| Hori, R; Hoshino, E; Kohno, S | 1 |
| Baertschi, SW; Collins, MW; Dorman, DE; Lorenz, LJ; Occolowitz, JL; Spangle, LA; Stephenson, GA | 1 |
| Baertschi, SW; Bashore, FN; Collins, MW; Dorman, DE; Lorenz, LJ; Occolowitz, JL; Spangle, LA | 1 |
| Chaimovich, H; De Oliveira, AG; Scarpa, MV | 1 |
| Barreto, DG; de la Torre, C; del Castillo, F; MacLoughlin, GJ; Palma, L; Pinetta, EA | 1 |
| Brookings, E; Gray, B; Swiatlo, E; Waites, K | 1 |
| Bianchi, P; Drehobl, M; Griffin, TJ; Keyserling, CH; Tack, KJ | 1 |
| al Sarraf, Z; Eeckhout, I; Naeyaert, JM; Noens, L; Ongenae, K; Schelfhout, A | 1 |
| Goldstein, FW | 1 |
| József, I | 1 |
| Derendorf, H; Schifferer, H; Sourgens, H | 1 |
| Chaushu, G; Chaushu, S; Weinberger, T | 1 |
| Asvanich, K; Fugpholngam, V; Srimuang, S; Tanphaichitra, D | 1 |
| Deguchi, K; Ishihara, R; Ishii, Y; Nakazawa, A; Suzuki, Y | 1 |
| Beghetti, M; Benson, L; Bohn, D; Wilson, GJ | 1 |
| Belousov, IuB; Efremenkova, OV; Komarova, VP; Sokolov, AV; Tishchenkova, IF | 1 |
| Lewellen, PL; Olsen, BA; Perry, FM; Snorek, SV | 1 |
| Verbist, L; Verhaegen, J | 1 |
| Felmingham, D; Grüneberg, RN; Harding, I; Robbins, MJ; Shrimpton, S; Tesfaslasie, Y | 1 |
| Ballard, RC; Crabbé, F; Dangor, Y; Grobbelaar, TM; Laga, M; van Dyck, E | 1 |
| Periti, P | 1 |
| Hasegawa, Y; Imai, C; Nakae, M; Osaka, K; Sasaki, H; Shibasaki, K; Sugahara, Y; Yasui, H | 1 |
| Kearns, GL; Reid, J; Rieder, MJ; Wheeler, JG | 1 |
| Preston, DA; Turik, M | 1 |
| Akimoto, Y; Fujii, A; Ikeda, M; Kaneda, T; Omata, H; Shibutani, J; Takato, T; Yamamoto, H | 1 |
| Braveny, I; Cremer, J; Milatovic, D; Wallrauch, C | 1 |
| Esparcia Navarro, M; García Callejo, FJ; Orts Alborch, MH; Pardo Mateu, L; Velert Vila, MM | 1 |
| Johns, D; Turik, MA | 1 |
| Kubo, S; Moriguchi, N; Yagi, K; Yamamoto, T; Yoshioka, K | 1 |
| Hirakata, Y; Igari, J; Kaku, M; Matsuda, J; Misawa, N; Mori, T; Murase, M; Nakamura, A; Nakamura, Y; Oguri, T; Shimada, J; Shimoura, M; Shitara, M; Tachibana, Y; Tazawa, S; Ugajin, K; Umezu, S | 1 |
| Dagan, R; Fliss, DM; Greenberg, D; Leiberman, A; Leibovitz, E; Yagupsky, P | 1 |
| Preston, D; Therasse, D; Zeckel, ML | 1 |
| Gould, IM; Mackenzie, FM; Milne, KE | 1 |
| Belousov, IuB; Efremenkova, OV; Komarova, VP | 1 |
| Boyd, IW | 1 |
| Aoki, K; Hayashi, M; Kawano, Y; Noma, T; Shikishima, Y; Yoshizawa, I | 1 |
| Cook, GK; Hornback, WJ; McDonald, JH; Munroe, JE; Snyder, NJ | 1 |
| Dillman, CA; Kierszenbaum, JS; Macias, MP; Ramos, BD; Soliman, AE; Subba Rao, SD | 1 |
| de Boisblanc, BP; Haponik, E; Karam, G; Nelson, S; Omidvari, K; Summer, W | 1 |
| Clairoux, N; Huletsky, A; Knox, JR; Levesque, RC; Sanschagrin, F; Trépanier, S | 1 |
| Grouhi, M; Hummel, D; Roifman, CM | 1 |
| Nash, MC; Parshuram, CS; Phillips, RJ | 1 |
| Kitayama, R; Minami, S; Mitsuyama, J; Watanabe, Y; Yamada, H | 1 |
| Preston, DA | 1 |
| Phillips, R | 1 |
| Chiu, HH; Chiu, TF; Hsueh, PR; Huang, LM; Lee, CY; Lee, PI; Lin, HC; Lu, CY; Tsai, HY | 1 |
| Gloor, J; Hadad, K; Joubert, GI; Matsui, D; Rieder, MJ | 1 |
| Allen, BS; Bandak, SI; Bolzon, LD; Henle, SK; Johns, D; Turnak, MR | 1 |
| Fogg, AG; Rodrigues, LN; Zanoni, MV | 1 |
| Belal, F; El-Shabrawy, Y; Hefnawy, M | 1 |
| Kishimoto, K; Koike, S; Kumeda, S; Nakamura, T; Nakazawa, K; Shigematsu, H; Shimizu, T; Shimozawa, N; Watanabe, T | 1 |
| Meyers, BR | 1 |
| Hanaki, H; Hiramatsu, K; Inaba, Y | 1 |
| Chiba, A; Harada, S; Hasegawa, M; Kaneko, A; Kobayashi, I; Koyama, H; Matsuzaki, K; Omika, K; Sasaki, J; Sato, Y | 1 |
| Esposito, S; Mazzei, T; Novelli, A; Periti, P | 1 |
| Hoban, DJ; Karlowsky, JA; Verma, G; Zhanel, GG | 1 |
| Beach, ML; Biedenbach, DJ; Johnson, DM; Jones, RN; Pfaller, MA | 1 |
| Boveri, B; Cazzola, M; Centanni, S; Di Marco, F; Di Perna, F; Diamare, F | 1 |
| Ibia, EO; Schwartz, RH; Wiedermann, BL | 1 |
| Gupta, S; Prasad, BB | 1 |
| De Soyza, A; Gould, K; Higgins, B | 1 |
| Hotary, LH; Keyserling, CH; Leigh, AP; Nemeth, MA; Tack, KJ | 1 |
| Allen, BS; Bandak, SI; Bolzon, LD; Preston, DA; Turnak, MR | 1 |
| Barry, AL; Brown, SD; Fuchs, PC | 1 |
| Erhardt, W; Knirsch, C; Murphy, M | 1 |
| Bozkurt, A; Deniz, M; Yegen, BC | 1 |
| Bernardini, R; Lombardi, E; Novembre, E; Pucci, N; Rossi, ME; Vierucci, A | 1 |
| Aqil, S; Bukhari, KA; Gaba, I; Hassan, M; Hassan, S; Iqbal, A; Khan, MK; Khawar, N; Malik, BA; Malik, S; Masood, T; Najam, Y; Sharif, MW; Tarar, MA; Walla, FL | 1 |
| Preston, DA; Turnak, MR | 1 |
| Hashido, H; Ishigo, S; Iwata, I; Matsubara, S; Matsukawa, Y; Mikamo, H; Sawamura, H; Suematsu, H; Tamaya, T | 1 |
| Jung, SH; Kang, SH | 1 |
| Al-Ammar, AY | 1 |
| Alam, SM; Dham, R; Jarrar, O; Musameh, M; Tutunji, M | 1 |
| Furudoi, S; Komori, T; Ohtsuka, Y; Yoshii, T; Yoshikawa, T; Yoshioka, A | 1 |
| Clarke, AR; Spencer, J; Walsh, TR | 1 |
| Isaacs, D | 1 |
| Dalla Costa, T; De La Peña, A; Derendorf, H; Gross, J; Müller, M; Rehak, E; Talton, JD; Thyroff-Friesinger, U; Webb, AI | 1 |
| D'Errico, G; Esposito, S; Ianniello, F; Noviello, S | 1 |
| Chen, Y; Hao, F; Li, J; Zhang, Y | 1 |
| Chyczewska, E; Grzelewska-Rzymowska, I; Haczyński, J; Malolepszy, J; Marcinkowska-Suchowierska, E; Milanowski, J; Oklek, K; Płusa, T; Rek, M; Szmygin, K; Słominski, J | 1 |
| Aguilar-Cota, ME; Flores-Murrieta, FJ; Granados-Soto, V; Herrera, JE; Medina-Santillán, R; Reyes-García, G | 1 |
| Dabrowski, MP; Stankiewicz, W | 1 |
| Amores, R; Calvo, A; Prieto, J; Sevillano, D; Valero, E | 1 |
| Brunner, M; de, lP; Derendorf, H; Eichler, HG; Gross, J; Müller, M; Rehak, E; Thyroff-Friesinger, U | 1 |
| Abdulla, EM; Ahmed, A; Awan, A; Azim, R; Fareed, A; Hafiz, S; Hussain, S; Khan, KZ; Rafiq, M; Siddiqui, SJ; Tariq, N | 1 |
| Furugo, I; Ishida, M; Takii, M; Ueda, M | 1 |
| Guo, WB; Lin, YS; Ni, KY; Wu, ZJ; Zhang, QG | 1 |
| Abe, T; Fukuoka, T; Ito, K; Sato, Y; Sei, M | 1 |
| Baquero, F; Baquero, MR; Galán, JC; Morosini, MI; Reig, M | 1 |
| Caronzolo, D; Fraschini, F; Pintucci, JP; Scaglione, F | 1 |
| Wei, DZ; Yang, L | 1 |
| Alpan, RS; Erenmemisoglu, A; Gatchev, E; Koytchev, R; Ozalp, Y; Tyutyulkova, N | 1 |
| Gao, L; Li, Y; Liu, J; Liu, Y; Lü, Y; Xiao, YH | 1 |
| Deng, LP; Du, YP; Jiang, XT | 1 |
| Endou, H; Kuroda, M; Kusuhara, H; Sugiyama, Y | 1 |
| Heidron, F; Knothe, H; Sammann, A; Schäfer, V | 1 |
| Andrasi, M; Buglyo, P; Gaspar, A; Zekany, L | 1 |
| Hur, JK; Kang, JH; Kim, JH; Lee, KY; Lee, SY | 1 |
| Chen, D; Song, Z; Wang, Z | 1 |
| Correra, TC; Hu, CQ; Li, J; Maître, P; Qian, JQ; Song, DQ | 1 |
| Cao, J; Chui, D; Huang, H; Wang, H; Xiao, S | 1 |
| Baldo, BA | 1 |
| Doo, GE; Ha, CY; Jang, JH; Kim, SC; Lee, HY; Lee, Y; Nam, HJ; Nam, YH; Rhyou, HI; Woo, SD; Ye, YM | 1 |
| Shi, CY; Wang, JF; Ying, HZ | 1 |
19 review(s) available for cephalosporin c and cefaclor anhydrous
| Article | Year |
|---|---|
Comparison of cefprozil with other antibiotic regimens in the treatment of children with acute otitis media.
Topics: Acute Disease; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Infective Agents; Cefaclor; Cefixime; Cefotaxime; Cefprozil; Cephalosporins; Child; Child, Preschool; Clavulanic Acids; Drug Therapy, Combination; Humans; Infant; Otitis Media with Effusion | 1992 |
Treatment of pharyngitis and tonsillitis with cefprozil: review of three multicenter trials.
Topics: Cefaclor; Cefprozil; Cephalosporins; Erythromycin; Humans; Penicillins; Pharyngitis; Tonsillitis | 1992 |
Review of the experience with cefprozil for the treatment of lower respiratory tract infections.
Topics: Acute Disease; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Bronchitis; Bronchopneumonia; Cefaclor; Cefprozil; Cefuroxime; Cephalosporins; Clavulanic Acids; Drug Therapy, Combination; Humans; Pneumonia, Pneumococcal | 1992 |
Clinical trials of cefprozil for treatment of skin and skin-structure infections: review.
Topics: Cefaclor; Cefprozil; Cellulitis; Cephalosporins; Erythromycin; Humans; Skin Diseases, Infectious | 1992 |
Antibiotic therapy for urinary tract infections.
Topics: Cefaclor; Cephalosporins; Clinical Trials as Topic; Europe; Female; Humans; Male; Norfloxacin; United States; Urinary Tract Infections | 1992 |
Pharmacokinetics of the new cephalosporins.
Topics: Cefaclor; Cefadroxil; Cefamandole; Cefazolin; Cefmetazole; Cefonicid; Cefoperazone; Cefotaxime; Cefotiam; Cefsulodin; Ceftizoxime; Cephalexin; Cephalosporins; Cephamycins; Cephradine; Humans; Intestinal Absorption; Kinetics; Moxalactam; Tissue Distribution | 1982 |
The cephalosporins: activity and clinical use.
Topics: Cefaclor; Cefamandole; Cefatrizine; Cefazolin; Cefoxitin; Cefuroxime; Cephacetrile; Cephalexin; Cephaloglycin; Cephaloridine; Cephalosporins; Cephalothin; Cephapirin; Drug Hypersensitivity; Humans; Kidney Diseases | 1980 |
Comparative efficacy and safety of cefprozil versus penicillin, cefaclor and erythromycin in the treatment of streptococcal pharyngitis and tonsillitis.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Cefaclor; Cefprozil; Cephalosporins; Child; Child, Preschool; Erythromycin; Female; Humans; Male; Middle Aged; Multicenter Studies as Topic; Penicillins; Pharyngitis; Randomized Controlled Trials as Topic; Streptococcal Infections; Streptococcus pyogenes; Tonsillitis | 1994 |
Efficacy and safety of cefprozil versus other beta-lactam antibiotics in the treatment of lower respiratory tract infections.
Topics: Adolescent; Adult; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacterial Infections; Bronchitis; Cefaclor; Cefprozil; Cefuroxime; Cephalosporins; Clavulanic Acids; Drug Therapy, Combination; Female; Humans; Male; Multicenter Studies as Topic; Pneumonia; Prodrugs; Randomized Controlled Trials as Topic; Respiratory Tract Infections | 1994 |
Multi-investigator evaluation of the efficacy and safety of cefprozil, amoxicillin-clavulanate, cefixime and cefaclor in the treatment of acute otitis media.
Topics: Acute Disease; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacterial Infections; Cefaclor; Cefixime; Cefotaxime; Cefprozil; Cephalosporins; Child; Child, Preschool; Clavulanic Acids; Drug Therapy, Combination; Female; Humans; Infant; Male; Microbial Sensitivity Tests; Multicenter Studies as Topic; Otitis Media; Randomized Controlled Trials as Topic | 1994 |
Comparative studies of cefprozil in the management of skin and soft-tissue infections.
Topics: Adolescent; Adult; Aged; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacterial Infections; Cefaclor; Cefprozil; Cephalosporins; Child; Child, Preschool; Clavulanic Acids; Clinical Trials as Topic; Drug Therapy, Combination; Erythromycin; Female; Humans; Male; Middle Aged; Multicenter Studies as Topic; Skin Diseases, Bacterial; Soft Tissue Infections | 1994 |
Management of otitis media. A review.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Cefaclor; Cefixime; Cefotaxime; Cefuroxime; Cephalosporins; Child; Humans; Otitis Media; Penicillins; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination | 1995 |
A case of drug eruption due to simultaneous sensitization with three different kinds of drugs.
Topics: Amoxapine; Cefaclor; Cephalosporins; Drug Eruptions; Drug Hypersensitivity; Female; Humans; Mexiletine; Middle Aged; Multiple Chemical Sensitivity; Patch Tests; Selective Serotonin Reuptake Inhibitors | 1996 |
Pharmacokinetic profile of cefaclor.
Topics: Aged; Antacids; Area Under Curve; Cefaclor; Cephalosporins; Child; Cimetidine; Drug Interactions; Half-Life; Humans; Infant; Renal Insufficiency; Theophylline | 1997 |
Immunopharmacology of oral betalactams.
Topics: Adjuvants, Immunologic; Administration, Oral; Animals; Anti-Bacterial Agents; Cefaclor; Cephalosporins; Chemotaxis; Humans; Microbial Sensitivity Tests; Neutrophils; Phagocytes; T-Lymphocytes, Helper-Inducer | 1998 |
Serum sickness in a paediatric emergency department: the role of cefaclor.
Topics: Australia; Cefaclor; Cephalosporins; Child; Child, Preschool; Emergency Service, Hospital; Female; Humans; Incidence; Infant; Male; Prospective Studies; Retrospective Studies; Risk Assessment; Serum Sickness | 1999 |
Cefaclor into the millennium.
Topics: Bacterial Infections; Bronchitis; Cefaclor; Cephalosporins; Economics, Pharmaceutical; Ecosystem; Humans; Microbial Sensitivity Tests; Patient Compliance | 1999 |
[A case of rectal lues].
Topics: Adult; Cefaclor; Cephalosporins; Homosexuality, Male; Humans; Male; Proctitis; Rectum; Syphilis; Treatment Outcome; Treponema pallidum | 2000 |
Cefaclor revisited.
Topics: Biological Availability; Cefaclor; Cephalosporins; Delayed-Action Preparations; Humans; Respiratory Tract Infections | 2000 |
68 trial(s) available for cephalosporin c and cefaclor anhydrous
| Article | Year |
|---|---|
Probenecid: an unexplained effect on cephalosporin pharmacology.
Topics: Adolescent; Adult; Cefaclor; Cephalosporins; Cephradine; Drug Interactions; Female; Humans; Kinetics; Male; Middle Aged; Probenecid; Time Factors | 1979 |
Comparative study of cefprozil and cefaclor in children with bacterial infections of skin and skin structures.
Topics: Bacterial Infections; Cefaclor; Cefprozil; Cephalosporins; Child; Child, Preschool; Female; Humans; Male; Prospective Studies; Skin Diseases, Infectious; Staphylococcal Infections; Streptococcal Infections; Streptococcus pyogenes | 1992 |
[Bacteriological, pharmacokinetic and clinical studies of 5% and 10% granules of cefdinir in the pediatric field].
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Cefaclor; Cefdinir; Cefixime; Cefotaxime; Cephalosporins; Child; Child, Preschool; Dose-Response Relationship, Drug; Female; Humans; Infant; Male; Microbial Sensitivity Tests | 1992 |
Loracarbef vs. cefaclor in pediatric skin and skin structure infections.
Topics: Cefaclor; Cephalosporins; Child; Child, Preschool; Double-Blind Method; Female; Haemophilus Infections; Haemophilus influenzae; Humans; Infant; Male; Skin Diseases, Infectious; Staphylococcal Skin Infections; Staphylococcus aureus; Streptococcal Infections; Streptococcus pyogenes | 1992 |
Comparison of cefprozil with other antibiotic regimens in the treatment of children with acute otitis media.
Topics: Acute Disease; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Infective Agents; Cefaclor; Cefixime; Cefotaxime; Cefprozil; Cephalosporins; Child; Child, Preschool; Clavulanic Acids; Drug Therapy, Combination; Humans; Infant; Otitis Media with Effusion | 1992 |
Treatment of pharyngitis and tonsillitis with cefprozil: review of three multicenter trials.
Topics: Cefaclor; Cefprozil; Cephalosporins; Erythromycin; Humans; Penicillins; Pharyngitis; Tonsillitis | 1992 |
Review of the experience with cefprozil for the treatment of lower respiratory tract infections.
Topics: Acute Disease; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Bronchitis; Bronchopneumonia; Cefaclor; Cefprozil; Cefuroxime; Cephalosporins; Clavulanic Acids; Drug Therapy, Combination; Humans; Pneumonia, Pneumococcal | 1992 |
Clinical trials of cefprozil for treatment of skin and skin-structure infections: review.
Topics: Cefaclor; Cefprozil; Cellulitis; Cephalosporins; Erythromycin; Humans; Skin Diseases, Infectious | 1992 |
Loracarbef (LY163892) versus cefaclor in the treatment of bacterial skin and skin-structure infections in an adult population.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bacterial Infections; Cefaclor; Cephalosporins; Child; Double-Blind Method; Gastrointestinal Diseases; Headache; Humans; Incidence; Middle Aged; Skin Diseases, Infectious; Treatment Outcome | 1992 |
Loracarbef (LY163892) versus cefaclor and norfloxacin in the treatment of uncomplicated pyelonephritis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Cefaclor; Cephalosporins; Diarrhea; Double-Blind Method; Europe; Female; Headache; Humans; Male; Middle Aged; Nausea; Norfloxacin; Pyelonephritis; Treatment Outcome; United States | 1992 |
Ceftibuten versus cefaclor for the treatment of bronchitis.
Topics: Bacteria; Bronchitis; Cefaclor; Ceftibuten; Cephalosporins; Female; Humans; Male; Microbial Sensitivity Tests | 1991 |
Comparative efficacy and safety of cefprozil and cefaclor in the treatment of acute uncomplicated urinary tract infections.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Bacteria; Cefaclor; Cefprozil; Cephalosporins; Half-Life; Humans; Microbial Sensitivity Tests; Middle Aged; Urinary Tract Infections | 1991 |
Antimicrobial activity of RU29246 (HR916 metabolite) compared with four other oral beta-lactams tested against more than 5000 clinical isolates.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Cefaclor; Cefixime; Cefotaxime; Cephalexin; Cephalosporins; Clavulanic Acids; Drug Therapy, Combination; Enterococcus; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Staphylococcus; Streptococcus agalactiae | 1991 |
Comparative efficacy and safety of cefprozil (BMY-28100) and cefaclor in the treatment of acute group A beta-hemolytic streptococcal pharyngitis.
Topics: Adolescent; Adult; Aged; Cefaclor; Cefprozil; Cephalosporins; Female; Humans; Male; Middle Aged; Pharyngitis; Streptococcal Infections; Streptococcus pyogenes | 1991 |
Comparison of cefprozil and cefaclor for treatment of acute urinary tract infections in women.
Topics: Acute Disease; Adolescent; Adult; Cefaclor; Cefprozil; Cephalosporins; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Urinary Tract Infections | 1991 |
Loracarbef versus cefaclor in the treatment of urinary tract infections in women.
Topics: Cefaclor; Cephalosporins; Double-Blind Method; Female; Humans; Urinary Tract Infections | 1991 |
[Randomized study of cefatrizine versus cefaclor in conjunctivitis otitis syndrome].
Topics: Acute Disease; Cefaclor; Cefatrizine; Cephalexin; Cephalosporins; Child, Preschool; Conjunctivitis; Female; Humans; Infant; Male; Otitis Media; Prospective Studies; Randomized Controlled Trials as Topic | 1990 |
[Clinical evaluation of BMY-28100 for bacterial pneumonia in comparison with cefaclor in a double-blind study].
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Bacterial Infections; Cefaclor; Cefprozil; Cephalosporins; Double-Blind Method; Female; Humans; Male; Middle Aged; Pneumonia | 1990 |
Phase I study of multiple-dose cefprozil and comparison with cefaclor.
Topics: Adult; Body Fluids; Cefaclor; Cefprozil; Cephalexin; Cephalosporins; Drug Administration Schedule; Drug Evaluation; Humans; Male; Regression Analysis | 1990 |
Comparison of cefprozil and cefaclor pharmacokinetics and tissue penetration.
Topics: Administration, Oral; Adolescent; Adult; Blister; Body Fluids; Cefaclor; Cefprozil; Cephalexin; Cephalosporins; Humans; Male | 1990 |
Comparison of the effects of food on the pharmacokinetics of cefprozil and cefaclor.
Topics: Adult; Cefaclor; Cefprozil; Cephalexin; Cephalosporins; Food; Humans; Intestinal Absorption; Male | 1990 |
Single-dose cefuroxime axetil versus multiple-dose cefaclor in the treatment of acute urinary tract infections.
Topics: Acute Disease; Adult; Blood Chemical Analysis; Cefaclor; Cefuroxime; Cephalexin; Cephalosporins; Female; Humans; Urinary Tract Infections | 1989 |
Treatment of otitis media with cefuroxime axetil.
Topics: Acute Disease; Cefaclor; Cefuroxime; Cephalosporins; Child; Child, Preschool; Clinical Trials as Topic; Drug Administration Schedule; Drug Evaluation; Female; Humans; Infant; Male; Otitis Media with Effusion; Pharmaceutical Preparations; Prodrugs; Random Allocation | 1988 |
[Clinical evaluation of cefpodoxime proxetil in the treatment of skin and soft tissue infections. A double blind comparison of cefpodoxime proxetil and cefaclor].
Topics: Abscess; Administration, Oral; Adolescent; Adult; Aged; Cefaclor; Cefpodoxime Proxetil; Ceftizoxime; Cephalexin; Cephalosporins; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Male; Middle Aged; Multicenter Studies as Topic; Skin Diseases, Infectious; Staphylococcal Infections; Staphylococcus aureus | 1988 |
[Comparative clinical study of T-2588 and cefaclor in chronic respiratory tract infections by a double-blind method].
Topics: Adult; Aged; Aged, 80 and over; Bacterial Infections; Cefaclor; Cefmenoxime; Cephalexin; Cephalosporins; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Male; Middle Aged; Respiratory Tract Infections | 1986 |
[Comparative clinical study of CS-807 and cefaclor for bacterial pneumonia by a double-blind method].
Topics: Adolescent; Adult; Aged; Bacterial Infections; Cefaclor; Cefpodoxime Proxetil; Ceftizoxime; Cephalexin; Cephalosporins; Chemical Phenomena; Chemistry; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Male; Middle Aged; Multicenter Studies as Topic; Pneumonia | 1988 |
[Comparative clinical study of CS-807 and cefaclor in chronic respiratory tract infections by a double-blind method].
Topics: Adult; Aged; Aged, 80 and over; Cefaclor; Cefpodoxime Proxetil; Ceftizoxime; Cephalexin; Cephalosporins; Chronic Disease; Clinical Trials as Topic; Double-Blind Method; Female; Haemophilus Infections; Haemophilus influenzae; Humans; Male; Middle Aged; Multicenter Studies as Topic; Respiratory Tract Infections | 1988 |
Blinded comparison of cefuroxime to cefaclor for lower respiratory tract infections.
Topics: Acute Disease; Administration, Oral; Adult; Aged; Bacterial Infections; Bronchitis; Cefaclor; Cefuroxime; Cephalexin; Cephalosporins; Clinical Trials as Topic; Drug Therapy; Female; Humans; Male; Middle Aged; Pneumonia; Prodrugs; Random Allocation; Respiratory Tract Infections | 1988 |
Cefuroxime axetil in the treatment of uncomplicated UTI: a comparison with cefaclor and augmentin.
Topics: Adolescent; Adult; Aged; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Cefaclor; Cefuroxime; Cephalosporins; Clavulanic Acids; Clinical Trials as Topic; Drug Combinations; Female; Humans; Male; Middle Aged; Random Allocation; Urinary Tract Infections | 1987 |
Multinational multicenter controlled trial comparing ceftibuten with cefaclor for the treatment of acute otitis media. Members of the Ceftibuten Otitis Media International Study Group.
Topics: Acute Disease; Adolescent; Bacterial Infections; Cefaclor; Ceftibuten; Cephalosporins; Child; Child, Preschool; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Infant; Male; Otitis Media with Effusion; Prospective Studies; Single-Blind Method; Treatment Outcome | 1995 |
[Cephalosporin treatment of maxillary sinusitis].
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Bacterial Infections; Cefaclor; Cephalosporins; Double-Blind Method; Female; Haemophilus Infections; Humans; Male; Maxillary Sinusitis; Middle Aged; Prodrugs | 1995 |
Comparative efficacy and safety of cefprozil versus penicillin, cefaclor and erythromycin in the treatment of streptococcal pharyngitis and tonsillitis.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Cefaclor; Cefprozil; Cephalosporins; Child; Child, Preschool; Erythromycin; Female; Humans; Male; Middle Aged; Multicenter Studies as Topic; Penicillins; Pharyngitis; Randomized Controlled Trials as Topic; Streptococcal Infections; Streptococcus pyogenes; Tonsillitis | 1994 |
Efficacy and safety of cefprozil versus other beta-lactam antibiotics in the treatment of lower respiratory tract infections.
Topics: Adolescent; Adult; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacterial Infections; Bronchitis; Cefaclor; Cefprozil; Cefuroxime; Cephalosporins; Clavulanic Acids; Drug Therapy, Combination; Female; Humans; Male; Multicenter Studies as Topic; Pneumonia; Prodrugs; Randomized Controlled Trials as Topic; Respiratory Tract Infections | 1994 |
Multi-investigator evaluation of the efficacy and safety of cefprozil, amoxicillin-clavulanate, cefixime and cefaclor in the treatment of acute otitis media.
Topics: Acute Disease; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacterial Infections; Cefaclor; Cefixime; Cefotaxime; Cefprozil; Cephalosporins; Child; Child, Preschool; Clavulanic Acids; Drug Therapy, Combination; Female; Humans; Infant; Male; Microbial Sensitivity Tests; Multicenter Studies as Topic; Otitis Media; Randomized Controlled Trials as Topic | 1994 |
Factors influencing outcome in children treated with antibiotics for acute otitis media.
Topics: Acute Disease; Amoxicillin; Anti-Bacterial Agents; Cefaclor; Cefixime; Cefotaxime; Cephalosporins; Child; Child, Preschool; Clinical Trials as Topic; Female; Follow-Up Studies; Humans; Infant; Male; Otitis Media; Regression Analysis; Risk Factors; Treatment Outcome | 1993 |
[A randomized control study on the treatment of 123 cases of bacterial infections with cefteram and cefaclor].
Topics: Bacterial Infections; Bronchitis; Cefaclor; Cefmenoxime; Cephalosporins; Cystitis; Humans; Tonsillitis | 1995 |
An open study to compare azithromycin with cefaclor in the treatment of children with acute otitis media.
Topics: Acute Disease; Adolescent; Anti-Bacterial Agents; Azithromycin; Cefaclor; Cephalosporins; Child; Child, Preschool; Female; Humans; Infant; Male; Otitis Media | 1996 |
An open comparative study of azithromycin versus cefaclor in the treatment of patients with upper respiratory tract infections.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Azithromycin; Cefaclor; Cephalosporins; Female; Humans; Male; Middle Aged; Respiratory Tract Infections | 1996 |
A comparative study of the efficacy, safety and tolerability of azithromycin and cefaclor in the treatment of children with acute skin and/or soft tissue infections.
Topics: Acute Disease; Adolescent; Anti-Bacterial Agents; Azithromycin; Cefaclor; Cephalosporins; Child; Child, Preschool; Double-Blind Method; Female; Humans; Infant; Male; Skin Diseases, Infectious; Soft Tissue Infections | 1996 |
Cefuroxime axetil in the treatment of acute sinusitis in childhood.
Topics: Adolescent; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Cefaclor; Cefuroxime; Cephalosporins; Child; Child, Preschool; Clavulanic Acids; Female; Humans; Male; Pharynx; Sinusitis; Staphylococcus aureus; Streptococcus; Treatment Outcome | 1996 |
Effects of prophylactic administration of cefaclor on transient bacteremia after dental extraction.
Topics: Adult; Aged; Bacteremia; Cefaclor; Cephalosporins; Double-Blind Method; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Tooth Extraction | 1996 |
Randomized controlled study of clarithromycin versus cefaclor suspensions in the treatment of acute otitis media in children.
Topics: Acute Disease; Anti-Bacterial Agents; Cefaclor; Cephalosporins; Child; Child, Preschool; Clarithromycin; Female; Humans; Infant; Male; Microbial Sensitivity Tests; Otitis Media; Suspensions | 1995 |
Impaired bacteriologic response to oral cephalosporins in acute otitis media caused by pneumococci with intermediate resistance to penicillin.
Topics: Acute Disease; Administration, Oral; Cefaclor; Cefuroxime; Cephalosporins; Child, Preschool; Drug Resistance, Microbial; Humans; Infant; Microbial Sensitivity Tests; Otitis Media; Penicillin Resistance; Pneumococcal Infections; Prospective Studies; Streptococcus pneumoniae | 1996 |
Cefpodoxime proxetil suspension compared with cefaclor suspension for treatment of acute otitis media in paediatric patients.
Topics: Acute Disease; Cefaclor; Cefpodoxime Proxetil; Ceftizoxime; Cephalosporins; Child; Child, Preschool; Female; Haemophilus Infections; Haemophilus influenzae; Humans; Infant; Male; Moraxella catarrhalis; Neisseriaceae Infections; Otitis Media; Prodrugs; Staphylococcal Infections; Staphylococcus aureus; Streptococcal Infections; Streptococcus pneumoniae; Streptococcus pyogenes; Suspensions | 1996 |
Comparison of cefdinir and cefaclor in treatment of community-acquired pneumonia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Cefaclor; Cefdinir; Cephalosporins; Community-Acquired Infections; Double-Blind Method; Female; Humans; Male; Middle Aged; Pneumonia, Bacterial; Treatment Outcome; United States | 1997 |
Bacteriologic response to oral cephalosporins: are established susceptibility breakpoints appropriate in the case of acute otitis media?
Topics: Acute Disease; Administration, Oral; Cefaclor; Cefuroxime; Cephalosporins; Child, Preschool; Female; Haemophilus influenzae; Humans; Infant; Male; Microbial Sensitivity Tests; Otitis Media; Streptococcus pneumoniae | 1997 |
Cefaclor, an alternative to third generation cephalosporins for the treatment of gonococcal urethritis in the developing world?
Topics: Administration, Oral; Cefaclor; Cephalosporins; Drug Therapy, Combination; Gonorrhea; Humans; Male; Microbial Sensitivity Tests; Probenecid; South Africa; Treatment Outcome; Urethritis; Uricosuric Agents | 1997 |
Azithromycin versus cefaclor in the treatment of pediatric patients with acute group A beta-hemolytic streptococcal tonsillopharyngitis.
Topics: Anti-Bacterial Agents; Azithromycin; Cefaclor; Cephalosporins; Child; Female; Humans; Male; Pharyngitis; Streptococcal Infections; Streptococcus pyogenes; Tonsillitis | 1998 |
[Comparison of azithromycin, amoxicillin/clavulanic acid and cefaclor in the treatment of acute ENT infections].
Topics: Acute Disease; Adult; Anti-Bacterial Agents; Azithromycin; Cefaclor; Cephalosporins; Clavulanic Acid; Female; Humans; Male; Maxillary Sinusitis; Otitis Media; Penicillins; Pharyngitis; Tonsillitis | 1998 |
Comparison of cefaclor and cefuroxime axetil in the treatment of acute otitis media with effusion in children who failed amoxicillin therapy.
Topics: Administration, Oral; Amoxicillin; Cefaclor; Cefuroxime; Cephalosporins; Child, Preschool; Female; Humans; Male; Otitis Media with Effusion; Penicillin Resistance; Penicillins; Single-Blind Method; Treatment Outcome | 1998 |
Early eradication of pathogens from middle ear fluid during antibiotic treatment of acute otitis media is associated with improved clinical outcome.
Topics: Acute Disease; Amoxicillin; Anti-Bacterial Agents; Azithromycin; Bacteria; Cefaclor; Cephalosporins; Child, Preschool; Female; Humans; Infant; Male; Otitis Media with Effusion; Penicillins; Prospective Studies; Treatment Outcome | 1998 |
Cefaclor and cefuroxime axetil in the treatment of otitis media--an alternative view.
Topics: Biomarkers; Cefaclor; Cefuroxime; Cephalosporins; Child; Humans; Otitis Media; Prodrugs; Random Allocation | 1998 |
[Selection of antibacterial therapy for treatment of infections in elderly patients].
Topics: Aged; Amoxicillin-Potassium Clavulanate Combination; Anti-Infective Agents; Cefaclor; Cephalosporins; Ciprofloxacin; Drug Therapy, Combination; Female; Fluoroquinolones; Humans; Male; Quinolones; Respiratory Tract Infections | 1998 |
A randomized, observer-blind trial of amoxycillin/clavulanate versus cefaclor in the treatment of children with acute otitis media. Augmentin 415 Study Group.
Topics: Acute Disease; Administration, Oral; Amoxicillin-Potassium Clavulanate Combination; Cefaclor; Cephalosporins; Child; Child, Preschool; Drug Therapy, Combination; Female; Humans; Infant; Male; Otitis Media; Single-Blind Method; Treatment Outcome | 1998 |
Early transition to oral antibiotic therapy for community-acquired pneumonia: duration of therapy, clinical outcomes, and cost analysis.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Cefaclor; Cefamandole; Cephalosporins; Community-Acquired Infections; Female; Health Care Costs; Hospitalization; Humans; Injections, Intravenous; Length of Stay; Male; Middle Aged; Pneumonia, Bacterial; Prospective Studies; Treatment Outcome | 1998 |
Comparison of once daily cefpodoxime proxetil suspension and thrice daily cefaclor suspension in the treatment of acute otitis media in children.
Topics: Acute Disease; Cefaclor; Cefpodoxime Proxetil; Ceftizoxime; Cephalosporins; Child; Child, Preschool; Drug Administration Schedule; Female; Humans; Infant; Male; Otitis Media; Suspensions | 1998 |
Cefaclor af versus amoxycillin/clavulanate in acute bacterial exacerbations of chronic bronchitis: a randomised multicentre study.
Topics: Adult; Aged; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacterial Infections; Bronchitis; Cefaclor; Cephalosporins; Chronic Disease; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Peak Expiratory Flow Rate; Single-Blind Method | 1999 |
Interrelationship between the pharmacokinetics and pharmacodynamics of cefaclor advanced formulation in patients with acute exacerbation of chronic bronchitis.
Topics: Acute Disease; Bronchitis; Cefaclor; Cephalosporins; Chronic Disease; Delayed-Action Preparations; Haemophilus Infections; Haemophilus influenzae; Humans; Microbial Sensitivity Tests; Moraxella catarrhalis; Neisseriaceae Infections; Pneumococcal Infections; Sputum; Streptococcus pneumoniae; Treatment Outcome | 2000 |
Cefdinir versus cefaclor in the treatment of uncomplicated urinary tract infection.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Cefaclor; Cefdinir; Cephalosporins; Double-Blind Method; Female; Humans; Male; Middle Aged; Treatment Outcome; Urinary Tract Infections | 2000 |
The efficacy and safety of cefaclor in respiratory infections amongst Pakistani children.
Topics: Bacterial Infections; Cefaclor; Cephalosporins; Child; Child, Preschool; Female; Follow-Up Studies; Humans; Infant; Male; Microbial Sensitivity Tests; Respiratory Tract Infections; Treatment Outcome | 2000 |
Bioequivalence evaluation of two brands of cefaclor 500 mg capsules: quantification of cefaclor using solid phase extraction technique.
Topics: Adolescent; Adult; Area Under Curve; Capsules; Cefaclor; Cephalosporins; Chromatography, High Pressure Liquid; Cross-Over Studies; Humans; Male | 2001 |
Short-course therapy with cefaclor for treatment of streptococcal pharyngotonsillitis.
Topics: Cefaclor; Cephalosporins; Child; Child, Preschool; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Penicillin V; Pharyngitis; Streptococcal Infections; Streptococcus pyogenes; Tonsillitis; Treatment Outcome | 2001 |
Comparative study of cefaclor AF vs. cefuroxime axetil in acute exacerbations of chronic bronchitis.
Topics: Adult; Aged; Aged, 80 and over; Bronchitis, Chronic; Cefaclor; Cefuroxime; Cephalosporins; Female; Humans; Male; Middle Aged; Single-Blind Method; Time Factors; Treatment Outcome | 2002 |
Oral pharmacokinetics of cefaclor in Mexican subjects.
Topics: Adult; Area Under Curve; Cefaclor; Cephalosporins; Half-Life; Humans; Male; Mexico | 2001 |
Comparative target site pharmacokinetics of immediate- and modified-release formulations of cefaclor in humans.
Topics: Adult; Cefaclor; Cephalosporins; Chemistry, Pharmaceutical; Cross-Over Studies; Delayed-Action Preparations; Extracellular Space; Humans; Male; Muscle, Skeletal; Tissue Distribution | 2002 |
Measurement of cefaclor and amoxicillin-clavulanic acid levels in middle-ear fluid in patients with acute otitis media.
Topics: Acute Disease; Adolescent; Amoxicillin-Potassium Clavulanate Combination; Area Under Curve; Body Fluids; Cefaclor; Cephalosporins; Child; Child, Preschool; Chromatography, High Pressure Liquid; Drug Therapy, Combination; Ear, Middle; Female; Humans; Male | 2003 |
Studies on the bioequivalence of second generation cephalosporins: cefaclor capsules and suspension.
Topics: Adolescent; Adult; Area Under Curve; Capsules; Cefaclor; Cephalosporins; Chromatography, High Pressure Liquid; Cross-Over Studies; Half-Life; Humans; Male; Suspensions; Tablets; Therapeutic Equivalency | 2004 |
[Comparative study on cefdinir and cefaclor in the treatment of patients with mild to moderate bacterial community acquired pneumonia].
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Cefaclor; Cefdinir; Cephalosporins; Community-Acquired Infections; Humans; Middle Aged; Pneumonia, Bacterial; Prospective Studies; Single-Blind Method; Staphylococcal Infections; Streptococcal Infections | 2004 |
168 other study(ies) available for cephalosporin c and cefaclor anhydrous
| Article | Year |
|---|---|
[Comparison of four recently introduced cephalosporins with respect to probability of resistance in multiresistant strains of Escherichia coli, Proteus mirabilis and Klebsiella spec. (author's transl)].
Topics: Anti-Bacterial Agents; Cefaclor; Cefamandole; Cefoxitin; Cefuroxime; Cephalosporins; Cephalothin; Drug Resistance, Microbial; Escherichia coli; Klebsiella; Proteus mirabilis; Species Specificity | 1979 |
[The distribution of minimal inhibitory concentrations of recently introduced cephalosporins in multiresistant strains of Escherichia coli, Proteus mirabilis and Klebsiella spec. as revealed by zone sizes of a standardized agar diffusion test (author's tr
Topics: Cefaclor; Cefamandole; Cefoxitin; Cefuroxime; Cephalosporins; Cephalothin; Drug Resistance, Microbial; Escherichia coli; Klebsiella; Microbial Sensitivity Tests; Proteus mirabilis | 1979 |
A pharmacological and in vitro comparison of three oral cephalosporins.
Topics: Administration, Oral; Bacteria; Cefaclor; Cephalexin; Cephalosporins; Cephradine; Chemical Phenomena; Chemistry; Female; Haemophilus influenzae; Humans; Male; Neisseria gonorrhoeae | 1979 |
[Antibacterial activity of cefotaxim in comparison with seven cephalosporins].
Topics: Bacteria; Cefaclor; Cefamandole; Cefazolin; Cefoxitin; Cefuroxime; Cephalexin; Cephalosporins; Cephalothin; Enterobacteriaceae; Escherichia coli; Humans; In Vitro Techniques; Pseudomonas | 1979 |
[Resistance of gram-negative bacteria against cefaclor and other antibiotics (author's transl)].
Topics: Cefaclor; Cephalexin; Cephalosporins; Drug Resistance, Microbial; Enterobacteriaceae; Escherichia coli; Klebsiella; Proteus; Serratia | 1979 |
[In vitro activity of oral cephalosporins (author's transl)].
Topics: Bacteria; beta-Lactamases; Cefaclor; Cephalexin; Cephalosporins; Cephalothin; Cephradine; Drug Resistance, Microbial; Escherichia coli; Peptidoglycan | 1979 |
Cefaclor and cefatrizine, new investigational orally administered cephalosporins. In-vitro collaborative evaluation against clinical bacterial isolates and comparison with related antimicrobics.
Topics: Administration, Oral; Bacteria; Cefaclor; Cefatrizine; Cephalexin; Cephalosporins; Cephalothin; Cephradine; Microbial Sensitivity Tests | 1979 |
The pharmacokinetics of the oral cephalosporins cefaclor, cephradine and cephalexin.
Topics: Adolescent; Adult; Cefaclor; Cephalexin; Cephalosporins; Cephradine; Female; Humans; Kinetics; Male; Time Factors | 1979 |
Antibacterial activity of the investigational oral and parenteral cephalosporin BK-218.
Topics: beta-Lactamases; Cefaclor; Cefixime; Cefotaxime; Cefuroxime; Cephalosporins; Ciprofloxacin; Drug Evaluation, Preclinical; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests | 1992 |
Cefdinir (FK482), an orally administered cephalosporin in vitro activity comparison against recent clinical isolates from five medical centers and determination of MIC quality control guidelines.
Topics: Anti-Bacterial Agents; Cefaclor; Cefadroxil; Cefdinir; Cefixime; Cefotaxime; Cefuroxime; Cephalosporins; Drug Evaluation, Preclinical; Enterobacteriaceae; Gram-Negative Aerobic Bacteria; Gram-Positive Cocci; Humans; Microbial Sensitivity Tests | 1992 |
In vitro susceptibility of Haemophilus influenzae to cefaclor, cefixime, cefetamet and loracarbef.
Topics: Ampicillin Resistance; Cefaclor; Cefixime; Cefotaxime; Ceftizoxime; Cephalosporins; Haemophilus influenzae; Microbial Sensitivity Tests; Regression Analysis | 1992 |
Effects of cefaclor, cefetamet and Ro 40-6890 on inflammatory responses of human granulocytes.
Topics: Cefaclor; Ceftizoxime; Cell Adhesion; Cephalosporins; Chemotaxis, Leukocyte; Granulocytes; Humans; In Vitro Techniques; Inflammation; Leukotrienes; Luminescent Measurements; Neutrophils; Phagocytosis | 1992 |
Cefaclor uptake by the proton-dependent dipeptide transport carrier of human intestinal Caco-2 cells and comparison to cephalexin uptake.
Topics: 2,4-Dinitrophenol; Adenocarcinoma; Amino Acids; Azides; Binding, Competitive; Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone; Carrier Proteins; Cefaclor; Cephalexin; Cephalosporins; Dinitrophenols; Dipeptides; Humans; Hydrogen-Ion Concentration; Intestinal Mucosa; Intestinal Neoplasms; Intestines; Kinetics; Nigericin; Oligomycins; Sodium Azide; Tumor Cells, Cultured | 1992 |
Development of revised quality control limits for disk diffusion susceptibility tests of selected cephem antibiotics with Haemophilus influenzae and description of a new control strain.
Topics: Ampicillin; Cefaclor; Cefamandole; Cefonicid; Cefuroxime; Cephalosporins; Evaluation Studies as Topic; Haemophilus influenzae; Humans; Microbial Sensitivity Tests; Quality Control; Reference Standards | 1992 |
Pharmaceutical properties of loracarbef: the remarkable solution stability of an oral 1-carba-1-dethiacephalosporin antibiotic.
Topics: Cefaclor; Cephalexin; Cephalosporins; Chromatography, High Pressure Liquid; Colorimetry; Crystallization; Drug Stability; Hydrogen-Ion Concentration; Isoelectric Focusing; Kinetics; Solubility; Solutions; Thermodynamics; X-Ray Diffraction | 1992 |
Comparative kill and growth rates determined with cefdinir and cefaclor and with Streptococcus pneumoniae and beta-lactamase-producing Haemophilus influenzae.
Topics: Cefaclor; Cefdinir; Cephalosporins; Colony Count, Microbial; Haemophilus influenzae; Humans; Microbial Sensitivity Tests; Streptococcus pneumoniae | 1992 |
Comparative in vitro activity of cefixime, cefaclor and loracarbef against urinary pathogens.
Topics: Anti-Infective Agents, Urinary; Bacteria; Cefaclor; Cefixime; Cefotaxime; Cephalosporins; Humans; Microbial Sensitivity Tests; Urinary Tract Infections | 1991 |
High-performance liquid chromatographic determination of loracarbef, a potential metabolite, cefaclor and cephalexin in human plasma, serum and urine.
Topics: Cefaclor; Cephalexin; Cephalosporins; Chromatography, High Pressure Liquid; Humans; Molecular Structure; Spectrophotometry, Ultraviolet | 1991 |
High-performance liquid chromatographic determination of cephalosporin antibiotics using 0.3 mm I.D. columns.
Topics: Cefaclor; Cefazolin; Ceftizoxime; Cephaloridine; Cephalosporins; Chromatography, High Pressure Liquid; Mass Spectrometry; Quality Control | 1991 |
In vivo efficacy of cefcanel daloxate in comparison with cefaclor.
Topics: Absorption; Animals; Bacterial Infections; Cefaclor; Cephalosporins; Disease Models, Animal; Escherichia coli Infections; Female; Klebsiella Infections; Klebsiella pneumoniae; Mice; Prodrugs; Staphylococcal Infections | 1990 |
[Comparative antibacterial activity of cefpodoxime, cefuroxime and cefaclor against strict anaerobic bacteria].
Topics: Anti-Bacterial Agents; Bacteria, Anaerobic; Cefaclor; Cefpodoxime; Ceftizoxime; Cefuroxime; Cephalexin; Cephalosporins; Dose-Response Relationship, Drug; In Vitro Techniques | 1990 |
Comparative evaluation of cefuroxime axetil and cefaclor for treatment of acute bacterial maxillary sinusitis.
Topics: Acute Disease; Adult; Aged; Bacterial Infections; beta-Lactamases; Cefaclor; Cefuroxime; Cephalexin; Cephalosporins; Drug Evaluation; Female; Haemophilus influenzae; Humans; Male; Maxillary Sinusitis; Middle Aged; Moraxella catarrhalis; Prodrugs; Streptococcus pneumoniae | 1989 |
Comparative antibacterial activity of the new cephalosporin cefcanel against anaerobic bacteria.
Topics: Ampicillin; Bacteria, Anaerobic; Bacteroides; Bacteroides fragilis; beta-Lactamases; Cefaclor; Cefadroxil; Cefazolin; Cephalexin; Cephalosporins; Clostridium perfringens; Fusobacterium; Humans; Microbial Sensitivity Tests; Penicillin V | 1989 |
In vitro and in vivo antibacterial activity of KT3777, a new orally active carbacephem.
Topics: Administration, Oral; Animals; Bacterial Infections; Cefaclor; Cephalexin; Cephalosporins; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Male; Mice; Microbial Sensitivity Tests | 1989 |
Cephalosporin for acne vulgaris.
Topics: Acne Vulgaris; Adult; Cefaclor; Cefadroxil; Cephalosporins; Female; Humans | 1986 |
The effect of antimicrobial agents on fecal flora of children.
Topics: Administration, Oral; Adolescent; Ampicillin; Anti-Bacterial Agents; Bacteria; Cefaclor; Ceftazidime; Cephalosporins; Child; Child, Preschool; Erythromycin; Feces; Gentamicins; Humans; Infant; Injections, Intravenous; Methicillin; Penicillin V; Yeasts | 1986 |
In vitro activities of selected new and long-acting cephalosporins against Pasteurella multocida.
Topics: Cefaclor; Cefixime; Cefoperazone; Cefotaxime; Ceftriaxone; Cephalosporins; Cephalothin; Cloxacillin; Erythromycin; Humans; Microbial Sensitivity Tests; Moxalactam; Oxacillin; Pasteurella; Penicillin G; Penicillin V | 1986 |
BMY 28100, a new oral cephalosporin.
Topics: Animals; Bacteria; Cefaclor; Cefprozil; Cephalexin; Cephalosporins; Clostridium; Enterobacteriaceae; Haemophilus influenzae; Kinetics; Listeria monocytogenes; Male; Mice; Microbial Sensitivity Tests; Neisseriaceae; Propionibacterium acnes; Staphylococcus; Streptococcus | 1987 |
In vitro activity of Ro 19-5247 (T-2525) and interpretive criteria for disk diffusion susceptibility testing.
Topics: Acinetobacter; Amoxicillin; Bacteria; Cefaclor; Cefmenoxime; Cefuroxime; Cephalexin; Cephalosporins; Clavulanic Acid; Clavulanic Acids; Enterobacteriaceae; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Staphylococcus; Streptococcus | 1987 |
In vitro activity and beta-lactamase stability of LY163892.
Topics: Administration, Oral; Bacteria; beta-Lactamases; Cefaclor; Cefotaxime; Cephalexin; Cephalosporins; Enzyme Stability | 1988 |
In vitro evaluation of ceftibuten (7432-S, SCH 39720), a novel orally administered cephalosporin.
Topics: Administration, Oral; Cefaclor; Cefixime; Cefotaxime; Ceftibuten; Cefuroxime; Cephalexin; Cephalosporins; Enterobacteriaceae; Haemophilus influenzae; Microbial Sensitivity Tests; Moraxella catarrhalis; Neisseria meningitidis; Streptococcus | 1988 |
Phase I clinical studies of 7432-S: effect of 7432-S on platelet aggregation and blood coagulation.
Topics: Adenosine Diphosphate; Adult; Animals; Anti-Bacterial Agents; Blood Coagulation; Cefaclor; Cefotaxime; Ceftibuten; Ceftizoxime; Cephalexin; Cephalosporins; Collagen; Dose-Response Relationship, Drug; Drug Evaluation; Humans; Male; Moxalactam; Partial Thromboplastin Time; Platelet Aggregation; Prothrombin Time; Rats; Rats, Inbred Strains; Time Factors | 1988 |
Antimicrobial activity of LY163892, an orally administered 1-carbacephem.
Topics: Bacteria; Cefaclor; Cephalexin; Cephalosporins; Microbial Sensitivity Tests | 1988 |
In vivo antibacterial activity of FK482, a new orally active cephalosporin.
Topics: Administration, Oral; Animals; Bacterial Infections; Cefaclor; Cefdinir; Cephalosporins; Male; Mice; Mice, Inbred ICR; Pneumonia; Pyelonephritis; Rabbits | 1988 |
In vitro activity of BMY-28100, a new oral cephalosporin.
Topics: Cefaclor; Cefprozil; Cephalosporins; Haemophilus influenzae; Microbial Sensitivity Tests; Staphylococcus aureus | 1988 |
Disk diffusion susceptibility testing for LY163892 (KT-3777), a new orally administered 1-carbacephem.
Topics: Bacteria; Cefaclor; Cephalexin; Cephalosporins; Enterobacter; Haemophilus influenzae; Microbial Sensitivity Tests; Predictive Value of Tests; Providencia | 1988 |
BMY-28100, a new oral cephalosporin: antimicrobial activity against nearly 7,000 recent clinical isolates, comparative potency with other oral agents, and activity against beta-lactamase producing isolates.
Topics: Administration, Oral; Bacteria, Anaerobic; beta-Lactamases; Cefaclor; Cefprozil; Cephalexin; Cephalosporins; Enterobacteriaceae; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; In Vitro Techniques; Microbial Sensitivity Tests | 1988 |
In vitro activity of an oral iminomethoxy aminothiazolyl cephalosporin, R-3746.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; beta-Lactamases; Cefaclor; Cefixime; Cefotaxime; Cefpodoxime; Ceftizoxime; Cefuroxime; Cephalexin; Cephalosporins; Clavulanic Acids; Culture Media; Drug Combinations; Drug Stability; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1988 |
Clinical pharmacokinetics of five oral cephalosporins in calves.
Topics: Absorption; Administration, Oral; Animals; Biological Availability; Cattle; Cefaclor; Cefadroxil; Cefatrizine; Cephalexin; Cephalosporins; Cephradine; Drug Evaluation; Escherichia coli; Injections, Intravenous; Male; Pasteurella; Salmonella | 1987 |
In vitro activities of LY163892, cefaclor, and cefuroxime.
Topics: Anti-Bacterial Agents; Bacteria; Cefaclor; Cefuroxime; Cephalexin; Cephalosporins; Drug Stability; Temperature | 1988 |
Antimicrobial activity of U-76,252 (CS-807), a new orally administered cephalosporin ester, including recommendations for MIC quality control.
Topics: Administration, Oral; Cefaclor; Cefpodoxime; Cefpodoxime Proxetil; Ceftizoxime; Cephalexin; Cephalosporins; Cephradine; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Quality Control | 1988 |
Comparative in vitro activity of cefetamet (RO 15-8074).
Topics: Ampicillin; Cefaclor; Cefotaxime; Cefotiam; Ceftizoxime; Cephalosporins; Enterobacteriaceae | 1987 |
Effect of an educational intervention on oral cephalosporin use in primary care.
Topics: Administration, Oral; Adolescent; Adult; Aged; Cefaclor; Cephalexin; Cephalosporins; Child; Child, Preschool; Cross-Sectional Studies; Drug Utilization; Education, Medical, Continuing; Family Practice; Humans; Infant; Middle Aged; Utilization Review | 1987 |
Antimicrobial activity of Ro 15-8074, active metabolite of a new oral cephalosporin (Ro 15-8075), against 7,775 recent clinical isolates.
Topics: Anti-Bacterial Agents; beta-Lactamases; Cefaclor; Ceftizoxime; Cefuroxime; Cephalosporins; Enterobacteriaceae; Humans; Microbial Sensitivity Tests; Plasmids; Pseudomonas; Staphylococcus | 1986 |
In vitro activity of BMY-28100, a new oral cephalosporin.
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Proteins; beta-Lactamases; Cefaclor; Cefprozil; Cephalexin; Cephalosporins; Microbial Sensitivity Tests | 1987 |
In vitro and in vivo antibacterial activities of T-2588, a new oral cephalosporin, compared with those of other oral beta-lactam antibiotics.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Bacterial Proteins; beta-Lactamases; Carrier Proteins; Cefaclor; Cefmenoxime; Cephalexin; Cephalosporins; Chemical Phenomena; Chemistry; Hexosyltransferases; Male; Mice; Mice, Inbred ICR; Muramoylpentapeptide Carboxypeptidase; Penicillin-Binding Proteins; Peptidyl Transferases; Protein Binding | 1987 |
In vitro and in vivo evaluations of BMY-28100, a new oral cephalosporin.
Topics: Animals; Bacteria, Aerobic; Bacterial Infections; beta-Lactamases; Cefaclor; Cefprozil; Cephalexin; Cephalosporins; Mice; Microbial Sensitivity Tests; Rats | 1987 |
In vitro activity and beta-lactamase stability of the oral cephalosporin BMY-28100.
Topics: Cefaclor; Cefprozil; Cephalosporins; Clostridium; Enterobacteriaceae; Gram-Negative Bacteria; Gram-Positive Bacteria; Haemophilus influenzae; Microbial Sensitivity Tests; Penicillinase; Staphylococcus; Streptococcus | 1987 |
Beta-lactamase hydrolysis and inhibition studies of the new 1-carbacephem LY163892.
Topics: beta-Lactamase Inhibitors; beta-Lactamases; Cefaclor; Cefotaxime; Cephaloridine; Cephalosporins; Hydrolysis | 1987 |
Determination of cefaclor and cephradine in serum by ion-pair reversed-phase chromatography.
Topics: Cefaclor; Cephalexin; Cephalosporins; Cephradine; Chromatography, High Pressure Liquid; Chromatography, Ion Exchange; Humans; Indicators and Reagents; Kinetics; Spectrophotometry, Ultraviolet | 1987 |
Liquid-chromatographic determination of five orally active cephalosporins--cefixime, cefaclor, cefadroxil, cephalexin, and cephradine--in human serum.
Topics: Cefaclor; Cefadroxil; Cefixime; Cefotaxime; Cephalexin; Cephalosporins; Cephradine; Chromatography, High Pressure Liquid; Humans; Reference Standards; Reference Values | 1987 |
In-vitro activity of Ro-15-8074, a new oral cephalosporin.
Topics: Ampicillin; Bacteria; Cefaclor; Cefadroxil; Ceftizoxime; Cephalosporins; Drug Combinations; Microbial Sensitivity Tests; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1985 |
In vitro activity of Ro 15-8074, a new oral cephalosporin, against Neisseria gonorrhoeae.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; beta-Lactamases; Cefaclor; Ceftizoxime; Cephalosporins; Clavulanic Acids; In Vitro Techniques; Microbial Sensitivity Tests; Neisseria gonorrhoeae | 1985 |
Physicochemical properties of amphoteric beta-lactam antibiotics. IV. First- and second-order degradations of cefaclor and cefatrizine in aqueous solution and kinetic interpretation of the intestinal absorption and degradation of the concentrated antibiot
Topics: Animals; Cefaclor; Cefatrizine; Cephalexin; Cephalosporins; Chemical Phenomena; Chemistry, Physical; Chromatography, High Pressure Liquid; Hydrogen-Ion Concentration; Intestinal Absorption; Kinetics; Male; Rats; Rats, Inbred Strains | 1985 |
Comparative in vitro activity of 1-oxa-beta-lactam (LY127935) and cefoperazone with other beta-lactam antibiotics against anaerobic bacteria.
Topics: Anaerobiosis; Anti-Bacterial Agents; Bacteria; beta-Lactamases; beta-Lactams; Cefaclor; Cefoperazone; Cefotaxime; Cefoxitin; Cefsulodin; Cefuroxime; Cephalosporins; Cephamycins; Culture Media; Microbial Sensitivity Tests; Moxalactam | 1980 |
A comparison of the activity in vitro of different cephalosporins: cephalothin, cephradine, cephacetrile, cefaclor, cefuroxime and cefotaxime.
Topics: Cefaclor; Cefotaxime; Cefuroxime; Cephacetrile; Cephalosporins; Cephalothin; Cephradine; Enterobacter; Microbial Sensitivity Tests; Pseudomonas aeruginosa | 1980 |
Comparison of in vitro antibacterial activity of four oral cephems: cephalexin, cefaclor, cefatrizine and cefadroxil.
Topics: Bacteria; Cefaclor; Cefadroxil; Cefatrizine; Cephalexin; Cephalosporins; Escherichia coli; Microbial Sensitivity Tests; Proteus; Staphylococcus | 1984 |
Mechanism of action of the new orally active cephalosporin FK027.
Topics: Amoxicillin; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carrier Proteins; Cefaclor; Cefixime; Cephalexin; Cephalosporins; Enterobacter; Escherichia coli; Hexosyltransferases; Muramoylpentapeptide Carboxypeptidase; Penicillin-Binding Proteins; Peptidyl Transferases; Staphylococcus aureus | 1984 |
In vitro and in vivo antibacterial properties of FK 027, a new orally active cephem antibiotic.
Topics: Amoxicillin; Animals; Bacteria; Bacteria, Aerobic; Bacteria, Anaerobic; Bacterial Infections; Cefaclor; Cefixime; Cephalexin; Cephalosporins; Mice; Penicillin Resistance | 1984 |
Synthesis and antibacterial activities of new (alpha-hydrazinobenzyl)cephalosporins.
Topics: Bacteria; Cefaclor; Cephalexin; Cephaloglycin; Cephalosporins; Hydrazines; Indicators and Reagents; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Spectrophotometry, Infrared; Structure-Activity Relationship | 1983 |
High-pressure liquid chromatography and microbiological assay in the determination of serum levels using cefradine and cefaclor.
Topics: Adult; Bacillus subtilis; Cefaclor; Cephalexin; Cephalosporins; Cephradine; Chromatography, Liquid; Evaluation Studies as Topic; Female; Humans; Male | 1980 |
Comparison of the antibacterial spectra of cephalexin and cefaclor with those of cephalothin and newer cephalosporins: reevaluation of the class representative concept of susceptibility testing.
Topics: Bacteria; Cefaclor; Cephalexin; Cephalosporins; Cephalothin; Microbial Sensitivity Tests | 1983 |
Effects of ureteral obstruction on the toxicity of cephalosporins in the rabbit kidney.
Topics: Animals; Cefaclor; Cefazolin; Cephaloglycin; Cephaloridine; Cephalosporins; Constriction; Female; Kidney Cortex; Kidney Tubules, Proximal; Necrosis; Neomycin; Rabbits; Ureter | 1982 |
Benefits and risks of sequential parenteral--oral cephalosporin therapy for suppurative bone and joint infections.
Topics: Acute Disease; Administration, Oral; Arthritis, Infectious; Bacterial Infections; Cefaclor; Cefamandole; Cefuroxime; Cephalexin; Cephalosporins; Child; Child, Preschool; Drug Therapy, Combination; Female; Humans; Infant; Infusions, Parenteral; Male; Osteoarthritis; Osteomyelitis; Suppuration | 1982 |
Comparative pharmacokinetics of cefadroxil, cefaclor, cephalexin and cephradine in infants and children.
Topics: Administration, Oral; Cefaclor; Cefadroxil; Cephalexin; Cephalosporins; Cephradine; Child; Child, Preschool; Female; Humans; Infant; Infant, Newborn; Kinetics; Male; Time Factors | 1982 |
Pharmacokinetics of the oral cephalosporins in adults.
Topics: Adult; Cefaclor; Cefadroxil; Cephalexin; Cephalosporins; Cephradine; Humans; Kinetics | 1980 |
Estimation of the biliary excretion of different cephalosporins utilizing retrograde cholangio-pancreatography (ERCP).
Topics: Adult; Aged; Bile; Cefaclor; Cefamandole; Cefazolin; Cephalosporins; Cholangiopancreatography, Endoscopic Retrograde; Humans; Middle Aged | 1981 |
Interferences by cephalosporin antibiotics in urinary tests for metabolic disorders.
Topics: Cefaclor; Cephalosporins; Chromatography, Paper; Electrophoresis, Paper; False Positive Reactions; Humans; Metabolism, Inborn Errors; Molecular Structure; Ninhydrin; Staining and Labeling | 1995 |
In vitro susceptibilities of 185 penicillin-susceptible and -resistant pneumococci to WY-49605 (SUN/SY 5555), a new oral penem, compared with those to penicillin G, amoxicillin, amoxicillin-clavulanate, cefixime, cefaclor, cefpodoxime, cefuroxime, and cef
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Carbapenems; Cefaclor; Cefdinir; Cefixime; Cefotaxime; Cefpodoxime; Ceftizoxime; Cefuroxime; Cephalosporins; Clavulanic Acids; Microbial Sensitivity Tests; Penicillin G; Penicillin Resistance | 1994 |
Role of beta-lactamase of methicillin-susceptible Staphylococcus aureus in resistance to first-generation oral cephems both in vitro and in vivo.
Topics: Administration, Oral; Animals; Anti-Bacterial Agents; beta-Lactamases; Cefaclor; Cells, Cultured; Cephalosporins; Drug Resistance; Humans; Hydrolysis; Injections, Intraperitoneal; Male; Methicillin; Mice; Mice, Inbred Strains; Microbial Sensitivity Tests; Mutagenesis; Staphylococcus aureus | 1994 |
[Stability of various cephalosporins in solutions. Cefazolin, cefazedone, cefaclor].
Topics: Anti-Infective Agents, Urinary; Biotransformation; Catalysis; Cefaclor; Cefazolin; Cephalosporins; Drug Stability; Hydrogen-Ion Concentration; Kinetics; Solutions; Temperature; Thermodynamics | 1994 |
Revised disk diffusion interpretive criteria for cefaclor, loracarbef, cefprozil and cefixime when testing Haemophilus influenzae on haemophilus test medium.
Topics: Cefaclor; Cefixime; Cefotaxime; Cefprozil; Cephalosporins; Culture Media; Haemophilus Infections; Haemophilus influenzae; Humans; Microbial Sensitivity Tests; Quality Control | 1994 |
Comparative in-vitro activity of cefdinir against multiresistant Haemophilus influenzae.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Ampicillin Resistance; beta-Lactamases; Cefaclor; Cefdinir; Cefixime; Cefotaxime; Cefuroxime; Cephalosporins; Clavulanic Acids; Drug Resistance, Multiple; Haemophilus influenzae; Kinetics; Microbial Sensitivity Tests | 1994 |
FDA announces recall of liquid antibiotics.
Topics: Cefaclor; Cephalexin; Cephalosporins; Drug and Narcotic Control; United States; United States Food and Drug Administration | 1994 |
Susceptibility of United States clinical trial isolates to cefprozil and cefaclor.
Topics: Cefaclor; Cefprozil; Cephalosporins; Clinical Trials as Topic; Drug Resistance, Microbial; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; United States | 1994 |
Optimal times above MICs of ceftibuten and cefaclor in experimental intra-abdominal infections.
Topics: Abdomen; Animals; Bacterial Infections; Cefaclor; Ceftibuten; Cephalosporins; Female; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Half-Life; Mice; Time Factors | 1994 |
The pharmacokinetics, tissue penetration and in-vitro activity of loracarbef, a beta-lactam antibiotic of the carbacephem class.
Topics: Adult; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Cefaclor; Cephalosporins; Clavulanic Acids; Drug Therapy, Combination; Enterobacteriaceae; Exudates and Transudates; Haemophilus influenzae; Half-Life; Humans; Male; Microbial Sensitivity Tests; Moraxella catarrhalis; Staphylococcus aureus; Streptococcus pneumoniae | 1993 |
Aqueous acidic degradation of the carbacephalosporin loracarbef.
Topics: Cefaclor; Cephalosporins; Chromatography, High Pressure Liquid; Drug Stability; Hydrogen-Ion Concentration; Magnetic Resonance Spectroscopy; Mass Spectrometry; Molecular Structure; Solutions | 1993 |
In vitro effect on group A streptococci of loracarbef versus cefadroxil, cefaclor and penicillin V.
Topics: Anti-Bacterial Agents; Cefaclor; Cefadroxil; Cephalosporins; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Penicillin V; Pharyngitis; Streptococcal Infections; Streptococcus pyogenes | 1993 |
Comparison of the efficacy and safety of ceftibuten and cefaclor in the treatment of pneumonia and bronchiectasis.
Topics: Adolescent; Adult; Aged; Bacteria; Bacterial Infections; Bronchiectasis; Cefaclor; Ceftibuten; Cephalosporins; Female; Humans; Male; Middle Aged; Pneumonia | 1993 |
Atypical cerebral aneurysm in a young child.
Topics: Aneurysm, Infected; Aneurysm, Ruptured; Cefaclor; Cephalosporins; Child, Preschool; Fatal Outcome; Female; Humans; Intracranial Aneurysm | 1995 |
Case report: cheilitis granulomatosa with periodontitis.
Topics: Adult; Anti-Inflammatory Agents; Cefaclor; Cephalosporins; Humans; Male; Melkersson-Rosenthal Syndrome; Molar; Periodontitis; Tooth Extraction | 1995 |
Cefaclor serum sickness.
Topics: Cefaclor; Cephalosporins; Child; Drug Hypersensitivity; Humans; Proteinuria; Recurrence | 1996 |
Analytical investigation of beta-lactam antibiotics in pharmaceutical preparations. IX. Colorimetric determination of six cephalosporins of second and third generation in the range of micromolar concentrations.
Topics: Cefaclor; Cefamandole; Cefotaxime; Cefoxitin; Cefuroxime; Cephalosporins; Colorimetry; Indicators and Reagents; Molecular Structure; Sensitivity and Specificity | 1996 |
Bactericidal activities of cefprozil, penicillin, cefaclor, cefixime, and loracarbef against penicillin-susceptible and -resistant Streptococcus pneumoniae in an in vitro pharmacodynamic infection model.
Topics: Cefaclor; Cefixime; Cefotaxime; Cefprozil; Cephalosporins; Colony-Forming Units Assay; Humans; Microbial Sensitivity Tests; Models, Theoretical; Penicillin Resistance; Penicillins; Streptococcus pneumoniae | 1996 |
Cefaclor concentration in pus from abscess caused by odontogenic infection after a single oral administration.
Topics: Administration, Oral; Adult; Cefaclor; Cephalosporins; Female; Humans; Male; Microbial Sensitivity Tests; Periodontal Abscess; Suppuration | 1996 |
Molecular modeling study of structural requirements for the oligopeptide transporter.
Topics: Biological Transport, Active; Carrier Proteins; Cefaclor; Cephalosporins; Humans; Models, Molecular; Molecular Structure; Oligopeptides | 1996 |
Cefaclor and serum sickness-like reaction.
Topics: Cefaclor; Cephalosporins; Drug Contamination; Humans; Serum Sickness; Suspensions | 1996 |
In vitro activity of cefdinir against respiratory pathogens isolated in Sicily with reference to beta-lactamase production.
Topics: Administration, Oral; Amoxicillin; Anti-Bacterial Agents; beta-Lactamases; Cefaclor; Cefdinir; Cefuroxime; Cephalosporins; Clavulanic Acid; Clavulanic Acids; Drug Resistance, Microbial; Erythromycin; Haemophilus influenzae; Moraxella catarrhalis; Penicillins; Sicily; Streptococcus pneumoniae; Streptococcus pyogenes; Structure-Activity Relationship | 1996 |
Interactions of cephradine and cefaclor with the intestinal absorption of D-galactose.
Topics: Animals; Cefaclor; Cephalosporins; Cephradine; Diffusion; Galactose; In Vitro Techniques; Intestinal Absorption; Jejunum; Male; Microvilli; Perfusion; Rats; Rats, Wistar; Sodium-Potassium-Exchanging ATPase | 1996 |
Cefaclor-associated serum sickness-like reaction.
Topics: Canada; Cefaclor; Cephalosporins; Child; Child, Preschool; Humans; Infant; Serum Sickness; Time Factors | 1996 |
Comparative in-vitro activity of cefaclor against urinary tract isolates of Escherichia coli.
Topics: Ampicillin; Cefaclor; Cephalosporins; Community-Acquired Infections; Escherichia coli; Humans; Microbial Sensitivity Tests; Penicillins; Urinary Tract Infections | 1996 |
Photo quiz. Blepharitis due to herpes simplex virus type 1.
Topics: Acyclovir; Administration, Oral; Age Factors; Antiviral Agents; Blepharitis; Cefaclor; Cephalosporins; Child, Preschool; Diagnosis, Differential; Female; Herpes Simplex; Herpesvirus 1, Human; Humans; Impetigo; Recurrence | 1997 |
Bactericidal eradication from carious lesions of prepared abutments by an antibacterial temporary cement.
Topics: Adult; Anti-Bacterial Agents; Bacteria; Cefaclor; Cephalosporins; Ciprofloxacin; Colony Count, Microbial; Crowns; Dental Abutments; Dental Caries; Dental Leakage; Dental Restoration, Temporary; Humans; Metronidazole; Middle Aged; Polycarboxylate Cement; Tooth Preparation, Prosthodontic | 1997 |
Isolation and structure elucidation of the major degradation products of cefaclor formed under aqueous acidic conditions.
Topics: Cefaclor; Cephalosporins; Chromatography, High Pressure Liquid; Fluorescence; Hydrogen-Ion Concentration; Molecular Structure; Spectrum Analysis; Thiazoles; Water | 1997 |
Isolation and structure elucidation of the major degradation products of cefaclor in the solid state.
Topics: Cefaclor; Cephalosporins; Chromatography, High Pressure Liquid; Fluorescence; Molecular Structure; Oxidation-Reduction; Spectrum Analysis | 1997 |
Effect of hexadecyltrimethylammonium bromide-based microemulsions on the rate of decomposition of the beta-lactam antibiotic cephaclor.
Topics: Catalysis; Cefaclor; Cephalosporins; Cetrimonium; Cetrimonium Compounds; Emulsions; Kinetics; Thermodynamics | 1997 |
In vitro activities of oral antimicrobial agents against penicillin-resistant Streptococcus pneumoniae: implications for outpatient treatment.
Topics: Administration, Oral; Adult; Ambulatory Care; Anti-Bacterial Agents; Azithromycin; Cefaclor; Cefprozil; Cefuroxime; Cephalosporins; Child; Clarithromycin; Clindamycin; Culture Media; Humans; Penicillin Resistance; Pneumococcal Infections; Streptococcus pneumoniae; Tetracycline; Trimethoprim, Sulfamethoxazole Drug Combination | 1997 |
Acute generalized exanthematic pustulosis: a case with a lymphoma-like presentation.
Topics: Acute Disease; Adult; Biopsy, Needle; Cefaclor; Cephalosporins; Diagnosis, Differential; Drug Eruptions; Exanthema; Female; Humans; Lymphoma; Pharyngitis; Skin Diseases, Papulosquamous | 1997 |
Choice of an oral beta-lactam antibiotic for infections due to penicillin-resistant Streptococcus pneumoniae.
Topics: Administration, Oral; Amoxicillin; beta-Lactam Resistance; Cefaclor; Cefixime; Cefotaxime; Cefpodoxime; Ceftizoxime; Cefuroxime; Cephalosporins; Humans; Microbial Sensitivity Tests; Penicillin Resistance; Penicillins; Pneumococcal Infections; Protein Binding; Streptococcus pneumoniae | 1997 |
[Cefaclor allergy and Epstein-Barr virus infection].
Topics: Cefaclor; Cephalosporins; Drug Hypersensitivity; Fatigue Syndrome, Chronic; Humans | 1997 |
Infraorbital abscess from orthodontic headgear.
Topics: Abscess; Administration, Oral; Cefaclor; Cephalosporins; Child; Equipment Failure; Extraoral Traction Appliances; Female; Humans; Orbit; Orbital Diseases; Wounds, Penetrating | 1997 |
Cefaclor therapy in uncomplicated cystitis.
Topics: Administration, Oral; Adolescent; Adult; Cefaclor; Cephalosporins; Cystitis; Enterobacteriaceae; Female; Follow-Up Studies; Humans; Male; Middle Aged; Prospective Studies | 1997 |
[The drug susceptibility pattern of the presumed etiologic agents of infectious enteritis including verotoxin-producing Escherichia coli O-157].
Topics: Aerobiosis; Ampicillin; Anaerobiosis; Anti-Bacterial Agents; Anti-Infective Agents; Campylobacter jejuni; Cefaclor; Cephalosporins; Chloramphenicol; Drug Resistance, Microbial; Enteritis; Escherichia coli O157; Fosfomycin; Humans; Microbial Sensitivity Tests; Minocycline; Norfloxacin; Penicillins; Salmonella; Tetracycline; Vibrio parahaemolyticus | 1997 |
Hypersensitivity myocarditis caused by an allergic reaction to cefaclor.
Topics: Biopsy; Cefaclor; Cephalosporins; Child; Drug Hypersensitivity; Female; Humans; Myocarditis | 1998 |
[Treatment of lower respiratory tract infections in the elderly].
Topics: Aged; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Anti-Infective Agents; Area Under Curve; Bronchitis; Cefaclor; Cephalosporins; Chronic Disease; Ciprofloxacin; Cost-Benefit Analysis; Drug Therapy, Combination; Humans; Microbial Sensitivity Tests; Middle Aged; Ofloxacin; Penicillins | 1997 |
Accelerated conditions for stability assessment of bulk and formulated cefaclor monohydrate.
Topics: Administration, Oral; Capsules; Cefaclor; Cephalosporins; Chemistry, Pharmaceutical; Drug Stability; Evaluation Studies as Topic; Linear Models; Time Factors | 1997 |
In-vitro activity of 21 beta-lactam antibiotics against penicillin-susceptible and penicillin-resistant Streptococcus pneumoniae.
Topics: Amoxicillin; Ampicillin; Anti-Bacterial Agents; beta-Lactams; Carbapenems; Cefaclor; Cefadroxil; Cefatrizine; Cefepime; Cefixime; Cefotaxime; Cefpirome; Cefpodoxime; Ceftazidime; Ceftibuten; Ceftizoxime; Ceftriaxone; Cefuroxime; Cephalosporins; Cephradine; Drug Resistance, Microbial; Drug Resistance, Multiple; Humans; Microbial Sensitivity Tests; Penicillin Resistance; Penicillins; Piperacillin; Pneumococcal Infections; Serotyping; Species Specificity; Streptococcus pneumoniae | 1998 |
Antimicrobial susceptibility of community-acquired lower respiratory tract bacterial pathogens isolated in the UK during the 1995-1996 cold season.
Topics: Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Ampicillin Resistance; Anti-Bacterial Agents; Bacteria; Bacterial Infections; beta-Lactam Resistance; beta-Lactamases; Cefaclor; Cephalosporins; Ciprofloxacin; Clarithromycin; Common Cold; Community-Acquired Infections; Dose-Response Relationship, Drug; Haemophilus influenzae; Humans; Microbial Sensitivity Tests; Moraxella catarrhalis; Multicenter Studies as Topic; Penicillins; Respiratory System; Respiratory Tract Infections; Streptococcus pneumoniae; United Kingdom | 1998 |
[Drug susceptibility of clinically isolated Helicobacter pylori].
Topics: Amoxicillin; Anti-Bacterial Agents; Cefaclor; Cephalosporins; Clarithromycin; Cross Reactions; Drug Resistance, Microbial; Erythromycin; Gastritis; Helicobacter pylori; Humans; Imipenem; Penicillins; Stomach Ulcer; Thienamycins | 1998 |
Serum sickness-like reaction to cefaclor: lack of in vitro cross-reactivity with loracarbef.
Topics: Cefaclor; Cell Death; Cephalosporins; Child; Child, Preschool; Drug Hypersensitivity; Female; Humans; Infant; Lymphocytes; Male; Reproducibility of Results | 1998 |
Cefaclor: a contemporary look at susceptibility of key pathogens from around the globe.
Topics: Anti-Infective Agents; Cefaclor; Cephalosporins; Ciprofloxacin; Escherichia coli; Haemophilus influenzae; Methicillin Resistance; Microbial Sensitivity Tests; Moraxella catarrhalis; Penicillin Resistance; Staphylococcus aureus | 1998 |
Cefaclor concentration in radicular granuloma after a single oral administration.
Topics: Administration, Oral; Adult; Cefaclor; Cephalosporins; Drug Administration Schedule; Female; Granuloma; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Mouth Diseases | 1998 |
[The drug sensitivity of enterohemorragic Escherichia coli and antibiotics treatment for hemorrhagic enterocolitis--from an outbreak of enterocolitis in Sakai city].
Topics: Administration, Oral; Ampicillin; Anti-Bacterial Agents; Cefaclor; Cephalosporins; Child; Disease Outbreaks; Drug Resistance, Microbial; Enterocolitis; Escherichia coli Infections; Escherichia coli O157; Fosfomycin; Humans; Japan; Kanamycin; Penicillins | 1997 |
[Antimicrobial activities of roxithromycin against recently obtained clinical isolates].
Topics: Amoxicillin; Anti-Bacterial Agents; Cefaclor; Cephalosporins; Clarithromycin; Clindamycin; Drug Resistance, Microbial; Erythromycin; Humans; Leucomycins; Methicillin Resistance; Miocamycin; Moraxella catarrhalis; Mycoplasma pneumoniae; Penicillin Resistance; Penicillins; Roxithromycin; Staphylococcus aureus; Staphylococcus epidermidis; Streptococcus agalactiae; Streptococcus pneumoniae; Streptococcus pyogenes | 1997 |
The effects of the morphological response of Enterobacteriaceae to cephalosporins on PAE and CERT.
Topics: Cefaclor; Cefuroxime; Cephalosporins; Colony Count, Microbial; Culture Media; Electric Impedance; Enterobacteriaceae; Luminescent Measurements; Microbial Sensitivity Tests | 1998 |
Cefaclor-associated serum sickness.
Topics: Cefaclor; Cephalosporins; Humans; Serum Sickness | 1998 |
A comparative investigation of the restorative effects of roxithromycin on neutrophil activities.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Anti-Infective Agents; Aztreonam; Blood Bactericidal Activity; Cefaclor; Cephalosporins; Child; Disabled Persons; Drug Interactions; Female; Flow Cytometry; Humans; Hydrogen Peroxide; Macrophage-1 Antigen; Male; Monobactams; Neutrophils; Ofloxacin; Phagocytosis; Roxithromycin | 1998 |
3-trifluoromethylcarbacephems: synthesis of broad spectrum antibacterial compounds.
Topics: Bacteria; beta-Lactamases; Cefaclor; Cephalosporins; Chromosomes, Bacterial; Drug Design; Enterobacter; Escherichia coli; Gram-Negative Bacteria; Haemophilus influenzae; Indicators and Reagents; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Structure; Plasmids; Staphylococcus; Streptococcus; Structure-Activity Relationship | 1998 |
Structure-function studies of Ser-289 in the class C beta-lactamase from Enterobacter cloacae P99.
Topics: Bacterial Proteins; beta-Lactamases; Catalysis; Cefaclor; Cefazolin; Cephalosporins; Crystallography, X-Ray; Electrophoresis, Polyacrylamide Gel; Enterobacter cloacae; Escherichia coli; Hydrolysis; Kinetics; Microbial Sensitivity Tests; Models, Molecular; Mutagenesis, Site-Directed; Plasmids; Protein Conformation; Serine; Structure-Activity Relationship | 1999 |
Anaphylactic reaction to oral cefaclor in a child.
Topics: Administration, Oral; Anaphylaxis; Cefaclor; Cephalosporins; Child, Preschool; Drug Eruptions; Humans; Male; Otitis Media | 1999 |
Classification of Streptococcus pneumoniae based on in-vitro susceptibility to oxyiminocephalosporins.
Topics: Amoxicillin; Anti-Bacterial Agents; Cefaclor; Cefotiam; Cefuroxime; Cephalosporins; Humans; Japan; Microbial Sensitivity Tests; Penicillin G; Streptococcus pneumoniae | 1999 |
Interpretation of pneumococcal susceptibility tests with cefaclor.
Topics: Cefaclor; Cephalosporin Resistance; Cephalosporins; Humans; Microbial Sensitivity Tests; Penicillin Resistance; Penicillins; Streptococcus pneumoniae | 1999 |
New warning about cefaclor and serum sickness in children.
Topics: Adverse Drug Reaction Reporting Systems; Cefaclor; Cephalosporins; Child; Drug Industry; Drug Labeling; Humans; Incidence; Serum Sickness | 1999 |
Selection of treatment of cefaclor-associated urticarial, serum sickness-like reactions and erythema multiforme by emergency pediatricians: lack of a uniform standard of care.
Topics: Cefaclor; Cephalosporins; Child; Child, Preschool; Emergency Treatment; Erythema Multiforme; Histamine H1 Antagonists; Humans; Infant; Retrospective Studies; Serum Sickness; Urticaria | 1999 |
Indirect polarographic and cathodic stripping voltammetric determination of cefaclor as an alkaline degradation product.
Topics: Cefaclor; Cephalosporins; Humans; Polarography | 1999 |
Spectrofluorometric determination of alpha-aminocephalosporins in biological fluids and pharmaceutical preparations.
Topics: Cefaclor; Cefadroxil; Cephalexin; Cephalosporins; Cephradine; Fluorescamine; Humans; Hydrogen-Ion Concentration; Indicators and Reagents; Pharmaceutical Preparations; Reproducibility of Results; Spectrometry, Fluorescence | 1999 |
[Investigation of the antibacterial activity of faropenem against Streptococcus pneumoniae].
Topics: Anti-Bacterial Agents; beta-Lactams; Cefaclor; Cephalosporins; Drug Resistance, Microbial; Lactams; Penicillin G; Penicillin Resistance; Streptococcus pneumoniae | 1999 |
[In vitro activities of levofloxacin and other antibiotics against fresh clinical isolates].
Topics: Ampicillin; Anti-Infective Agents; Bacteria; Bacterial Infections; Cefaclor; Cefpodoxime; Ceftizoxime; Cephalosporins; Ciprofloxacin; Drug Resistance, Microbial; Humans; Levofloxacin; Methicillin; Ofloxacin; Penicillin G; Penicillin Resistance; Penicillins | 1999 |
New insight into the clinical pharmacokinetics of cefaclor: tissue penetration.
Topics: Aged; Blister; Cefaclor; Cephalosporins; Delayed-Action Preparations; Epithelium; Female; Half-Life; Humans; Male; Middle Aged; Pulmonary Alveoli; Tissue Distribution | 2000 |
Presence of ROB-1 beta-lactamase correlates with cefaclor resistance among recent isolates of Haemophilus influenzae.
Topics: beta-Lactamases; Canada; Cefaclor; Cephalosporin Resistance; Cephalosporins; Haemophilus Infections; Haemophilus influenzae; Humans; Reverse Transcriptase Polymerase Chain Reaction; United States | 2000 |
Antimicrobial activity and in vitro susceptibility test development for cefditoren against Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus species.
Topics: Cefaclor; Cefixime; Cephalosporins; Gram-Negative Bacterial Infections; Haemophilus Infections; Haemophilus influenzae; Humans; Microbial Sensitivity Tests; Moraxella catarrhalis; Penicillins; Streptococcal Infections; Streptococcus | 2000 |
Antibiotic rashes in children: a survey in a private practice setting.
Topics: Administration, Oral; Adolescent; Anti-Bacterial Agents; Cefaclor; Cephalosporins; Child; Child, Preschool; Drug Eruptions; Drug Hypersensitivity; Female; Humans; Infant; Male; Penicillins; Retrospective Studies; Sulfonamides | 2000 |
Determination of cefaclor by selective sample enrichment/clean-up on silica gel bonded polyelectrolyte in ion-exchange column chromatography.
Topics: Cefaclor; Cephalosporins; Chromatography, Ion Exchange; Electrolytes; Sensitivity and Specificity; Silica Gel; Silicon Dioxide; Spectrophotometry, Ultraviolet | 2000 |
An unusual case of pulmonary abscess.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Brain Abscess; Cefaclor; Cephalosporins; Diagnosis, Differential; Erythromycin; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Lung Abscess; Male; Metronidazole; Penicillins; Periodontal Abscess; Thoracic Vertebrae; Tomography, X-Ray Computed | 2000 |
Assessment of the susceptibility of Streptococcus pneumoniae to cefaclor and loracarbef in 13 countries.
Topics: Cefaclor; Cephalosporins; Europe; Humans; Microbial Sensitivity Tests; North America; Penicillin Resistance; Russia; Streptococcus pneumoniae | 2000 |
Susceptibility of Streptococcus pneumoniae and Haemophilus influenzae to cefditoren, and provisional interpretive criteria.
Topics: Ampicillin; Anti-Infective Agents; Cefaclor; Cefotaxime; Cephalosporin Resistance; Cephalosporins; Haemophilus influenzae; Microbial Sensitivity Tests; Ofloxacin; Penicillins; Streptococcus pneumoniae | 2000 |
Establishing criteria for assessment of efficacy of antimicrobial agents in acute otitis media.
Topics: Acute Disease; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Cefaclor; Cephalosporins; Clinical Trials as Topic; Humans; Otitis Media; Outcome Assessment, Health Care; Time Factors; Treatment Outcome | 2000 |
Cefaclor, a cephalosporin antibiotic, delays gastric emptying rate by a CCK-A receptor-mediated mechanism in the rat.
Topics: Animals; Aortic Bodies; Cefaclor; Cephalosporins; Cholecystokinin; Gastric Acid; Gastric Emptying; In Vitro Techniques; Intestines; Male; Neurons, Afferent; Rats; Rats, Sprague-Dawley; Receptor, Cholecystokinin A; Receptors, Cholecystokinin | 2000 |
Long persistence of IgE antibody to cefaclor.
Topics: Adolescent; Cefaclor; Cephalosporins; Drug Eruptions; Humans; Hypersensitivity, Immediate; Immunoglobulin E; Male; Time Factors | 2000 |
Assumed versus approved breakpoints.
Topics: Cefaclor; Cephalosporins; Drug Resistance, Microbial; Maximum Tolerated Dose; Microbial Sensitivity Tests; Streptococcus pneumoniae | 2000 |
[The frequency of Streptococcus pneumoniae strains and sensitivity surveillance for several antibiotics in Gifu Prefecture].
Topics: Amoxicillin; Anti-Bacterial Agents; Cefaclor; Cefdinir; Cefixime; Cefmenoxime; Cefpodoxime; Ceftizoxime; Cephalosporins; Ciprofloxacin; Clarithromycin; Clindamycin; Drug Resistance, Microbial; Fluoroquinolones; Humans; Imipenem; Japan; Levofloxacin; Meropenem; Microbial Sensitivity Tests; Minocycline; Naphthyridines; Ofloxacin; Penicillin G; Penicillins; Streptococcus pneumoniae; Thienamycins | 2000 |
Tests for 2 x K contingency tables with clustered ordered categorical data.
Topics: Amoxicillin; Animals; Cefaclor; Cephalosporins; Child, Preschool; Cluster Analysis; Computer Simulation; Humans; Infant; Lung Transplantation; Monte Carlo Method; Otitis Media with Effusion; Penicillins; Rabbits; Randomized Controlled Trials as Topic; Statistics, Nonparametric | 2001 |
Recurrent temporal petrositis.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Cefaclor; Cephalosporins; Child; Humans; Male; Middle Ear Ventilation; Ocular Motility Disorders; Otitis Media, Suppurative; Petrous Bone; Recurrence; Tomography, X-Ray Computed | 2001 |
Evaluation of oral antimicrobial agent levels in tooth extraction sites.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Alveolar Process; Anti-Bacterial Agents; Cefaclor; Cefdinir; Cefmenoxime; Cefuroxime; Cephalosporins; Female; Humans; Male; Middle Aged; Ofloxacin; Penicillins; Prodrugs; Staphylococcal Infections; Streptococcus; Talampicillin; Time Factors; Tooth Diseases; Tooth Extraction; Tooth Socket | 2001 |
Novel mechanism of hydrolysis of therapeutic beta-lactams by Stenotrophomonas maltophilia L1 metallo-beta-lactamase.
Topics: beta-Lactamases; Catalysis; Cefaclor; Cephalosporins; Dose-Response Relationship, Drug; Hydrolysis; Indicators and Reagents; Kinetics; Meropenem; Models, Chemical; Spectrometry, Fluorescence; Stenotrophomonas maltophilia; Temperature; Thienamycins; Time Factors; Tryptophan; Ultraviolet Rays | 2001 |
Serum sickness-like reaction to cefaclor.
Topics: Cefaclor; Cephalosporins; Child, Preschool; Drug Contamination; Erythema; Female; Humans; Infant; Joint Diseases; Serum Sickness; Suspensions; Urticaria | 2001 |
Penetration of cefaclor into the interstitial space fluid of skeletal muscle and lung tissue in rats.
Topics: Algorithms; Animals; Calibration; Cefaclor; Cephalosporins; Chromatography, High Pressure Liquid; Extracellular Space; Infusions, Intravenous; Injections, Intravenous; Lung; Male; Microdialysis; Muscle, Skeletal; Rats; Rats, Wistar; Spectrophotometry, Ultraviolet | 2001 |
E test for studying in vitro activity of seven antimicrobial agents against penicillin-susceptible and penicillin-resistant pneumococci.
Topics: Amoxicillin; Cefaclor; Cephalosporins; Community-Acquired Infections; Drug Resistance, Bacterial; Humans; Penicillin Resistance; Penicillins; Pneumococcal Infections; Respiratory Tract Infections; Streptococcus pneumoniae | 2000 |
Desirable and undesirable immunotropic effects of antibiotics: immunomodulating properties of cefaclor.
Topics: Adjuvants, Immunologic; Animals; Cefaclor; Cephalosporins; Humans; Immune System; Immunosuppressive Agents; Lymphocyte Activation; Neutrophils; Phagocytosis | 2001 |
[Activity of different antimicrobial agents against penicillin-resistant Streptococcus pneumoniae].
Topics: Amoxicillin; Anti-Bacterial Agents; Azithromycin; Cefaclor; Cefixime; Cefpodoxime; Ceftibuten; Ceftizoxime; Cefuroxime; Cephalosporins; Clavulanic Acid; Community-Acquired Infections; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Penicillin Resistance; Pneumonia, Pneumococcal; Spain; Streptococcus pneumoniae | 2001 |
Determination of antimicrobial activity of Cefaclor on common respiratory tract pathogens in Pakistan.
Topics: Cefaclor; Cephalosporins; Haemophilus influenzae; Humans; Microbial Sensitivity Tests; Moraxella catarrhalis; Respiratory Tract Infections; Streptococcus pneumoniae | 2002 |
[Microbiological and clinical studies of Haemophilus influenzae isolated at Kitakyushu Municipal Medical Center from 1996 through 1999].
Topics: Adult; Aged; Ampicillin; Anti-Infective Agents; beta-Lactamases; Cefaclor; Cephalosporins; Child, Preschool; Female; Haemophilus influenzae; Humans; Imipenem; Infant; Infant, Newborn; Levofloxacin; Male; Meningitis, Bacterial; Meropenem; Microbial Sensitivity Tests; Middle Aged; Ofloxacin; Respiratory System; Seasons; Sulbactam; Thienamycins | 2002 |
[Studies on the simultaneous measurement of several cephalosporins by RP-HPLC (I)].
Topics: Anti-Bacterial Agents; Cefaclor; Cefadroxil; Cephalexin; Cephalosporins; Cephradine; Chromatography, High Pressure Liquid | 1999 |
[Antibacterial activity of cefpodoxime against clinical isolates in 2000 and 2001].
Topics: Adolescent; Adult; Bacteria; Bacterial Infections; Cefaclor; Cefdinir; Cefpodoxime; Cefpodoxime Proxetil; Ceftizoxime; Cephalosporins; Child; Drug Resistance, Bacterial; Humans; Japan; Product Surveillance, Postmarketing; Time Factors | 2002 |
Haemophilus influenzae bla(ROB-1) mutations in hypermutagenic deltaampC Escherichia coli conferring resistance to cefotaxime and beta-lactamase inhibitors and increased susceptibility to cefaclor.
Topics: Amoxicillin-Potassium Clavulanate Combination; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; Cefaclor; Cefotaxime; Cephalosporin Resistance; Cephalosporins; Drug Therapy, Combination; Enzyme Inhibitors; Escherichia coli; Haemophilus influenzae; Kinetics; Microbial Sensitivity Tests; Mutation; Plasmids; Reverse Transcriptase Polymerase Chain Reaction | 2003 |
Enhanced enzymatic synthesis of a semi-synthetic cephalosprin, cefaclor, with in situ product removal.
Topics: Bioreactors; Cefaclor; Cephalosporins; Chromatography, High Pressure Liquid; Enzymes, Immobilized; Glycine; Hydrogen-Ion Concentration; Hydrolysis; Models, Chemical; Penicillin Amidase; Spectrophotometry; Substrate Specificity | 2003 |
[Comparison of pharmacokinetics/pharmacodynamics of cefdinir, cefpodoxime proxetil and cefaclor against common bacteria of community acquired infections].
Topics: Anti-Bacterial Agents; Cefaclor; Cefdinir; Cefpodoxime Proxetil; Ceftizoxime; Cephalosporins; Community-Acquired Infections; Humans; Microbial Sensitivity Tests; Staphylococcus aureus; Streptococcus pneumoniae | 2004 |
Rapid elimination of cefaclor from the cerebrospinal fluid is mediated by a benzylpenicillin-sensitive mechanism distinct from organic anion transporter 3.
Topics: Animals; Cefaclor; Cephalexin; Cephalosporins; Choroid Plexus; Chromatography, High Pressure Liquid; Depression, Chemical; Dipeptides; DNA, Complementary; Injections, Intraventricular; LLC-PK1 Cells; Male; Organic Anion Transporters, Sodium-Independent; Penicillin G; Penicillins; Rats; Rats, Sprague-Dawley; Spectrum Analysis; Swine; Symporters; Transfection | 2005 |
In vitro evaluation of Ly 163892, a new oral cephalosporin.
Topics: Anti-Bacterial Agents; Bacteria; Cefaclor; Cephalosporins; Microbial Sensitivity Tests | 1989 |
A comparative study of capillary zone electrophoresis and pH-potentiometry for determination of dissociation constants.
Topics: Anti-Bacterial Agents; Cefaclor; Cefadroxil; Cefoperazone; Cefotaxime; Cefoxitin; Cephalexin; Cephalosporins; Electrophoresis, Capillary; Hydrogen-Ion Concentration; Kinetics; Molecular Structure; Potentiometry | 2007 |
In vitro antimicrobial activity of cefditoren and other oral antibiotics against Streptococcus pneumoniae, isolated from children with community acquired respiratory tract infections.
Topics: Acute Disease; Amoxicillin; Anti-Bacterial Agents; Cefaclor; Cefdinir; Cefuroxime; Cephalosporins; Child; Child, Preschool; Community-Acquired Infections; Drug Resistance, Bacterial; Humans; Korea; Respiratory Tract Infections; Streptococcus pneumoniae | 2010 |
Study on the binding behavior of bovine serum albumin with cephalosporin analogues by chemiluminescence method.
Topics: Animals; Anti-Bacterial Agents; Cattle; Cefaclor; Cefadroxil; Cefazolin; Cefoperazone; Cefotaxime; Ceftriaxone; Cefuroxime; Cephalosporins; Cephradine; Luminescence; Luminescent Measurements; Phthalic Acids; Serum Albumin, Bovine; Thermodynamics; Tryptophan | 2010 |
Differentiation of cefaclor and its delta-3 isomer by electrospray mass spectrometry, infrared multiple photon dissociation spectroscopy and theoretical calculations.
Topics: Cefaclor; Cephalosporins; Isomerism; Quantum Theory; Spectrometry, Mass, Electrospray Ionization; Spectrophotometry, Infrared; Tandem Mass Spectrometry | 2015 |
Mass Spectral Profile for Rapid Differentiating Beta-Lactams from Their Ring-Opened Impurities.
Topics: Anti-Bacterial Agents; beta-Lactams; Cefaclor; Cefdinir; Cefixime; Cephalosporins; Chromatography, High Pressure Liquid; Humans; Mass Spectrometry | 2015 |
Cephalosporin allergens: Is the cephalosporoyl and R1 side-chain focus too narrow?
Topics: Allergens; Cefaclor; Cephalosporins; Epitopes; Humans; Immunoglobulin E | 2020 |
Cefaclor-induced hypersensitivity: Differences in the incidence of anaphylaxis relative to other 2nd and 3rd generation cephalosporins.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anaphylaxis; Cefaclor; Cephalosporins; Child; Child, Preschool; Drug Hypersensitivity; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Incidence; Infant; Infant, Newborn; Male; Middle Aged | 2021 |
Cephalosporins-induced intestinal dysbiosis exacerbated pulmonary endothelial barrier disruption in streptococcus pneumoniae-infected mice.
Topics: Animals; Anti-Bacterial Agents; Cefaclor; Cefdinir; Cefixime; Cephalosporins; Dysbiosis; Inflammation; Mice; Streptococcus pneumoniae | 2022 |